| Friday, June 28, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||
Room |
08:00 |
09:30 |
10:00 |
10:30 |
11:00 |
12:30 |
13:30 |
14:00 |
15:00 |
15:30 |
16:00 |
16:30 |
17:30 |
18:00 |
18:30 |
||||||||||||||||||||||||||||||||||
Room 1 - Alfredo Halpern |
SESSION Social media and Obesity 08:00 - 09:30
Coordinator: LUCIA HELENA DE OLIVEIRA (SP)
Social media and eating disorders in young people Speaker: TÁKI ATHANÁSSIOS CORDÁZ (SP) Social media and obesity: how to communicate correctly? Speaker: BRUNO HALPERN (SP) People with obesity perspective: stigma in the digital world Speaker: ERICKA CUZZIOL LIMA LUIZ (SP) Discussion
Coordinator: LUCIA HELENA DE OLIVEIRA (SP)
Social media and eating disorders in young people Speaker: TÁKI ATHANÁSSIOS CORDÁZ (SP) Social media and obesity: how to communicate correctly? Speaker: BRUNO HALPERN (SP) People with obesity perspective: stigma in the digital world Speaker: ERICKA CUZZIOL LIMA LUIZ (SP) Discussion
Coordinator: LUCIA HELENA DE OLIVEIRA (SP)
Social media and eating disorders in young people Speaker: TÁKI ATHANÁSSIOS CORDÁZ (SP) Social media and obesity: how to communicate correctly? Speaker: BRUNO HALPERN (SP) People with obesity perspective: stigma in the digital world Speaker: ERICKA CUZZIOL LIMA LUIZ (SP) Discussion
Coordinator: LUCIA HELENA DE OLIVEIRA (SP)
Social media and eating disorders in young people Speaker: TÁKI ATHANÁSSIOS CORDÁZ (SP) Social media and obesity: how to communicate correctly? Speaker: BRUNO HALPERN (SP) People with obesity perspective: stigma in the digital world Speaker: ERICKA CUZZIOL LIMA LUIZ (SP) Discussion
Coordinator: LUCIA HELENA DE OLIVEIRA (SP)
Social media and eating disorders in young people Speaker: TÁKI ATHANÁSSIOS CORDÁZ (SP) Social media and obesity: how to communicate correctly? Speaker: BRUNO HALPERN (SP) People with obesity perspective: stigma in the digital world Speaker: ERICKA CUZZIOL LIMA LUIZ (SP) Discussion |
KEYNOTE LECTURE How adipose tissue dysfunction can explain metabolic health and IR in obesity and T2D? 09:30 - 10:30
Chair: ERIC RAVUSSIN (United States)
Keynote Speaker: PHILIPP SCHERER (United States) Discussion
Chair: ERIC RAVUSSIN (United States)
Keynote Speaker: PHILIPP SCHERER (United States) Discussion
Chair: ERIC RAVUSSIN (United States)
Keynote Speaker: PHILIPP SCHERER (United States) Discussion |
BREAK 10:30 - 11:00 |
SYMPOSIUM IFSO-WOF The combination of drugs and surgery 11:00 - 12:30
Coordinator: EBAA AL OZAIRI (Kuwait)
Coordinator: RICARDO VITOR COHEN (SP) Long term outcomes and safety of metabolic surgery Speaker: RICARDO VITOR COHEN (SP) Will efficacious modern pharmacotherapy replace metabolic surgery? Speaker: EBAA AL OZAIRI (Kuwait) Improving the results of MS adding medical treatment Speaker: CAREL LE ROUX (Ireland) What can internists expect after sustained weight loss with pharmacotherapy: lessons learned from bariatric surgery Speaker: CARLOS SCHIAVON (SP) Uptake of obesity treatments: what do patients think Speaker: RICARDO VITOR COHEN (SP) Discussion
Coordinator: EBAA AL OZAIRI (Kuwait)
Coordinator: RICARDO VITOR COHEN (SP) Long term outcomes and safety of metabolic surgery Speaker: RICARDO VITOR COHEN (SP) Will efficacious modern pharmacotherapy replace metabolic surgery? Speaker: EBAA AL OZAIRI (Kuwait) Improving the results of MS adding medical treatment Speaker: CAREL LE ROUX (Ireland) What can internists expect after sustained weight loss with pharmacotherapy: lessons learned from bariatric surgery Speaker: CARLOS SCHIAVON (SP) Uptake of obesity treatments: what do patients think Speaker: RICARDO VITOR COHEN (SP) Discussion
Coordinator: EBAA AL OZAIRI (Kuwait)
Coordinator: RICARDO VITOR COHEN (SP) Long term outcomes and safety of metabolic surgery Speaker: RICARDO VITOR COHEN (SP) Will efficacious modern pharmacotherapy replace metabolic surgery? Speaker: EBAA AL OZAIRI (Kuwait) Improving the results of MS adding medical treatment Speaker: CAREL LE ROUX (Ireland) What can internists expect after sustained weight loss with pharmacotherapy: lessons learned from bariatric surgery Speaker: CARLOS SCHIAVON (SP) Uptake of obesity treatments: what do patients think Speaker: RICARDO VITOR COHEN (SP) Discussion
Coordinator: EBAA AL OZAIRI (Kuwait)
Coordinator: RICARDO VITOR COHEN (SP) Long term outcomes and safety of metabolic surgery Speaker: RICARDO VITOR COHEN (SP) Will efficacious modern pharmacotherapy replace metabolic surgery? Speaker: EBAA AL OZAIRI (Kuwait) Improving the results of MS adding medical treatment Speaker: CAREL LE ROUX (Ireland) What can internists expect after sustained weight loss with pharmacotherapy: lessons learned from bariatric surgery Speaker: CARLOS SCHIAVON (SP) Uptake of obesity treatments: what do patients think Speaker: RICARDO VITOR COHEN (SP) Discussion
Coordinator: EBAA AL OZAIRI (Kuwait)
Coordinator: RICARDO VITOR COHEN (SP) Long term outcomes and safety of metabolic surgery Speaker: RICARDO VITOR COHEN (SP) Will efficacious modern pharmacotherapy replace metabolic surgery? Speaker: EBAA AL OZAIRI (Kuwait) Improving the results of MS adding medical treatment Speaker: CAREL LE ROUX (Ireland) What can internists expect after sustained weight loss with pharmacotherapy: lessons learned from bariatric surgery Speaker: CARLOS SCHIAVON (SP) Uptake of obesity treatments: what do patients think Speaker: RICARDO VITOR COHEN (SP) Discussion
Coordinator: EBAA AL OZAIRI (Kuwait)
Coordinator: RICARDO VITOR COHEN (SP) Long term outcomes and safety of metabolic surgery Speaker: RICARDO VITOR COHEN (SP) Will efficacious modern pharmacotherapy replace metabolic surgery? Speaker: EBAA AL OZAIRI (Kuwait) Improving the results of MS adding medical treatment Speaker: CAREL LE ROUX (Ireland) What can internists expect after sustained weight loss with pharmacotherapy: lessons learned from bariatric surgery Speaker: CARLOS SCHIAVON (SP) Uptake of obesity treatments: what do patients think Speaker: RICARDO VITOR COHEN (SP) Discussion
Coordinator: EBAA AL OZAIRI (Kuwait)
Coordinator: RICARDO VITOR COHEN (SP) Long term outcomes and safety of metabolic surgery Speaker: RICARDO VITOR COHEN (SP) Will efficacious modern pharmacotherapy replace metabolic surgery? Speaker: EBAA AL OZAIRI (Kuwait) Improving the results of MS adding medical treatment Speaker: CAREL LE ROUX (Ireland) What can internists expect after sustained weight loss with pharmacotherapy: lessons learned from bariatric surgery Speaker: CARLOS SCHIAVON (SP) Uptake of obesity treatments: what do patients think Speaker: RICARDO VITOR COHEN (SP) Discussion
Coordinator: EBAA AL OZAIRI (Kuwait)
Coordinator: RICARDO VITOR COHEN (SP) Long term outcomes and safety of metabolic surgery Speaker: RICARDO VITOR COHEN (SP) Will efficacious modern pharmacotherapy replace metabolic surgery? Speaker: EBAA AL OZAIRI (Kuwait) Improving the results of MS adding medical treatment Speaker: CAREL LE ROUX (Ireland) What can internists expect after sustained weight loss with pharmacotherapy: lessons learned from bariatric surgery Speaker: CARLOS SCHIAVON (SP) Uptake of obesity treatments: what do patients think Speaker: RICARDO VITOR COHEN (SP) Discussion |
BREAK 12:30 - 14:00 |
SESSION Lipedema: An unknown disease 14:00 - 16:00
*Partnership with Lipedema Foundation
Coordinator: CRISTIANO ROBERTO GRIMALDI BARCELLOS (SP) Lipedema: understanding the clinical diagnosis and the research landscape Speaker: JONATHAN KARTT (United States) Physiopathology of lipedema Speaker: PHILIPP SCHERER (United States) Effect of weight loss in adipose tissue remodeling and metabolic function in women with Lipedema Speaker: VINCENZA CIFARELLI (United States) Diagnosis and clinical treatment options Speaker: ANDRÉ MURAD FARIA (SP) Surgical treatment Speaker: FABIO MASATO KAMAMOTO (SP) Patient´s voice – living with lipedema Speaker: TAMIRIS SÁ (RJ) Discussion
*Partnership with Lipedema Foundation
Coordinator: CRISTIANO ROBERTO GRIMALDI BARCELLOS (SP) Lipedema: understanding the clinical diagnosis and the research landscape Speaker: JONATHAN KARTT (United States) Physiopathology of lipedema Speaker: PHILIPP SCHERER (United States) Effect of weight loss in adipose tissue remodeling and metabolic function in women with Lipedema Speaker: VINCENZA CIFARELLI (United States) Diagnosis and clinical treatment options Speaker: ANDRÉ MURAD FARIA (SP) Surgical treatment Speaker: FABIO MASATO KAMAMOTO (SP) Patient´s voice – living with lipedema Speaker: TAMIRIS SÁ (RJ) Discussion
*Partnership with Lipedema Foundation
Coordinator: CRISTIANO ROBERTO GRIMALDI BARCELLOS (SP) Lipedema: understanding the clinical diagnosis and the research landscape Speaker: JONATHAN KARTT (United States) Physiopathology of lipedema Speaker: PHILIPP SCHERER (United States) Effect of weight loss in adipose tissue remodeling and metabolic function in women with Lipedema Speaker: VINCENZA CIFARELLI (United States) Diagnosis and clinical treatment options Speaker: ANDRÉ MURAD FARIA (SP) Surgical treatment Speaker: FABIO MASATO KAMAMOTO (SP) Patient´s voice – living with lipedema Speaker: TAMIRIS SÁ (RJ) Discussion
*Partnership with Lipedema Foundation
Coordinator: CRISTIANO ROBERTO GRIMALDI BARCELLOS (SP) Lipedema: understanding the clinical diagnosis and the research landscape Speaker: JONATHAN KARTT (United States) Physiopathology of lipedema Speaker: PHILIPP SCHERER (United States) Effect of weight loss in adipose tissue remodeling and metabolic function in women with Lipedema Speaker: VINCENZA CIFARELLI (United States) Diagnosis and clinical treatment options Speaker: ANDRÉ MURAD FARIA (SP) Surgical treatment Speaker: FABIO MASATO KAMAMOTO (SP) Patient´s voice – living with lipedema Speaker: TAMIRIS SÁ (RJ) Discussion
*Partnership with Lipedema Foundation
Coordinator: CRISTIANO ROBERTO GRIMALDI BARCELLOS (SP) Lipedema: understanding the clinical diagnosis and the research landscape Speaker: JONATHAN KARTT (United States) Physiopathology of lipedema Speaker: PHILIPP SCHERER (United States) Effect of weight loss in adipose tissue remodeling and metabolic function in women with Lipedema Speaker: VINCENZA CIFARELLI (United States) Diagnosis and clinical treatment options Speaker: ANDRÉ MURAD FARIA (SP) Surgical treatment Speaker: FABIO MASATO KAMAMOTO (SP) Patient´s voice – living with lipedema Speaker: TAMIRIS SÁ (RJ) Discussion
*Partnership with Lipedema Foundation
Coordinator: CRISTIANO ROBERTO GRIMALDI BARCELLOS (SP) Lipedema: understanding the clinical diagnosis and the research landscape Speaker: JONATHAN KARTT (United States) Physiopathology of lipedema Speaker: PHILIPP SCHERER (United States) Effect of weight loss in adipose tissue remodeling and metabolic function in women with Lipedema Speaker: VINCENZA CIFARELLI (United States) Diagnosis and clinical treatment options Speaker: ANDRÉ MURAD FARIA (SP) Surgical treatment Speaker: FABIO MASATO KAMAMOTO (SP) Patient´s voice – living with lipedema Speaker: TAMIRIS SÁ (RJ) Discussion
*Partnership with Lipedema Foundation
Coordinator: CRISTIANO ROBERTO GRIMALDI BARCELLOS (SP) Lipedema: understanding the clinical diagnosis and the research landscape Speaker: JONATHAN KARTT (United States) Physiopathology of lipedema Speaker: PHILIPP SCHERER (United States) Effect of weight loss in adipose tissue remodeling and metabolic function in women with Lipedema Speaker: VINCENZA CIFARELLI (United States) Diagnosis and clinical treatment options Speaker: ANDRÉ MURAD FARIA (SP) Surgical treatment Speaker: FABIO MASATO KAMAMOTO (SP) Patient´s voice – living with lipedema Speaker: TAMIRIS SÁ (RJ) Discussion
*Partnership with Lipedema Foundation
Coordinator: CRISTIANO ROBERTO GRIMALDI BARCELLOS (SP) Lipedema: understanding the clinical diagnosis and the research landscape Speaker: JONATHAN KARTT (United States) Physiopathology of lipedema Speaker: PHILIPP SCHERER (United States) Effect of weight loss in adipose tissue remodeling and metabolic function in women with Lipedema Speaker: VINCENZA CIFARELLI (United States) Diagnosis and clinical treatment options Speaker: ANDRÉ MURAD FARIA (SP) Surgical treatment Speaker: FABIO MASATO KAMAMOTO (SP) Patient´s voice – living with lipedema Speaker: TAMIRIS SÁ (RJ) Discussion
*Partnership with Lipedema Foundation
Coordinator: CRISTIANO ROBERTO GRIMALDI BARCELLOS (SP) Lipedema: understanding the clinical diagnosis and the research landscape Speaker: JONATHAN KARTT (United States) Physiopathology of lipedema Speaker: PHILIPP SCHERER (United States) Effect of weight loss in adipose tissue remodeling and metabolic function in women with Lipedema Speaker: VINCENZA CIFARELLI (United States) Diagnosis and clinical treatment options Speaker: ANDRÉ MURAD FARIA (SP) Surgical treatment Speaker: FABIO MASATO KAMAMOTO (SP) Patient´s voice – living with lipedema Speaker: TAMIRIS SÁ (RJ) Discussion |
REFRESHMENT BREAK AND POSTER SESSION 16:00 - 16:30 |
SESSION The challenge of weight maintenance 16:30 - 18:00
Coordinator: DEBORAH B. HORN (United States)
Coordinator: PAUL CAMPEROS (Venezuela, RB) Abstracts - 129826: EFFECTS OF MIRABEGRON AND QUINOLONE ON THE ACTIVATION OF BROWN ADIPOSE TISSUE IN HUMANS (MIRAQL-BAT STUDY) - Presenter: Marcelo Miranda de Oliveira de Lima Physiology of the weight loss plateau in response to lifestyle intervention, novel pharmacological therapy and bariatric surgery Speaker: KEVIN D. HALL (United States) How to reduce barriers for the long term pharmacological treatment of obesity? Speaker: NICHOLAS FINER (United Kingdom) What do we know about successful weight maintainers? Speaker: CINTIA CERCATO (SP) Discussion
Coordinator: DEBORAH B. HORN (United States)
Coordinator: PAUL CAMPEROS (Venezuela, RB) Abstracts - 129826: EFFECTS OF MIRABEGRON AND QUINOLONE ON THE ACTIVATION OF BROWN ADIPOSE TISSUE IN HUMANS (MIRAQL-BAT STUDY) - Presenter: Marcelo Miranda de Oliveira de Lima Physiology of the weight loss plateau in response to lifestyle intervention, novel pharmacological therapy and bariatric surgery Speaker: KEVIN D. HALL (United States) How to reduce barriers for the long term pharmacological treatment of obesity? Speaker: NICHOLAS FINER (United Kingdom) What do we know about successful weight maintainers? Speaker: CINTIA CERCATO (SP) Discussion
Coordinator: DEBORAH B. HORN (United States)
Coordinator: PAUL CAMPEROS (Venezuela, RB) Abstracts - 129826: EFFECTS OF MIRABEGRON AND QUINOLONE ON THE ACTIVATION OF BROWN ADIPOSE TISSUE IN HUMANS (MIRAQL-BAT STUDY) - Presenter: Marcelo Miranda de Oliveira de Lima Physiology of the weight loss plateau in response to lifestyle intervention, novel pharmacological therapy and bariatric surgery Speaker: KEVIN D. HALL (United States) How to reduce barriers for the long term pharmacological treatment of obesity? Speaker: NICHOLAS FINER (United Kingdom) What do we know about successful weight maintainers? Speaker: CINTIA CERCATO (SP) Discussion
Coordinator: DEBORAH B. HORN (United States)
Coordinator: PAUL CAMPEROS (Venezuela, RB) Abstracts - 129826: EFFECTS OF MIRABEGRON AND QUINOLONE ON THE ACTIVATION OF BROWN ADIPOSE TISSUE IN HUMANS (MIRAQL-BAT STUDY) - Presenter: Marcelo Miranda de Oliveira de Lima Physiology of the weight loss plateau in response to lifestyle intervention, novel pharmacological therapy and bariatric surgery Speaker: KEVIN D. HALL (United States) How to reduce barriers for the long term pharmacological treatment of obesity? Speaker: NICHOLAS FINER (United Kingdom) What do we know about successful weight maintainers? Speaker: CINTIA CERCATO (SP) Discussion
Coordinator: DEBORAH B. HORN (United States)
Coordinator: PAUL CAMPEROS (Venezuela, RB) Abstracts - 129826: EFFECTS OF MIRABEGRON AND QUINOLONE ON THE ACTIVATION OF BROWN ADIPOSE TISSUE IN HUMANS (MIRAQL-BAT STUDY) - Presenter: Marcelo Miranda de Oliveira de Lima Physiology of the weight loss plateau in response to lifestyle intervention, novel pharmacological therapy and bariatric surgery Speaker: KEVIN D. HALL (United States) How to reduce barriers for the long term pharmacological treatment of obesity? Speaker: NICHOLAS FINER (United Kingdom) What do we know about successful weight maintainers? Speaker: CINTIA CERCATO (SP) Discussion
Coordinator: DEBORAH B. HORN (United States)
Coordinator: PAUL CAMPEROS (Venezuela, RB) Abstracts - 129826: EFFECTS OF MIRABEGRON AND QUINOLONE ON THE ACTIVATION OF BROWN ADIPOSE TISSUE IN HUMANS (MIRAQL-BAT STUDY) - Presenter: Marcelo Miranda de Oliveira de Lima Physiology of the weight loss plateau in response to lifestyle intervention, novel pharmacological therapy and bariatric surgery Speaker: KEVIN D. HALL (United States) How to reduce barriers for the long term pharmacological treatment of obesity? Speaker: NICHOLAS FINER (United Kingdom) What do we know about successful weight maintainers? Speaker: CINTIA CERCATO (SP) Discussion
Coordinator: DEBORAH B. HORN (United States)
Coordinator: PAUL CAMPEROS (Venezuela, RB) Abstracts - 129826: EFFECTS OF MIRABEGRON AND QUINOLONE ON THE ACTIVATION OF BROWN ADIPOSE TISSUE IN HUMANS (MIRAQL-BAT STUDY) - Presenter: Marcelo Miranda de Oliveira de Lima Physiology of the weight loss plateau in response to lifestyle intervention, novel pharmacological therapy and bariatric surgery Speaker: KEVIN D. HALL (United States) How to reduce barriers for the long term pharmacological treatment of obesity? Speaker: NICHOLAS FINER (United Kingdom) What do we know about successful weight maintainers? Speaker: CINTIA CERCATO (SP) Discussion |
|||||||||||||||||||||||||||||||||||||||||
Room 2 - John Waterlow |
SESSION Obesity and the heart 08:00 - 09:30
Coordinator: VIVIANE ZORZANELLI ROCHA GIRALDEZ (SP)
Coordinator: AMELIO FERNANDO GODOY MATOS (RJ) Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets Speaker: ANDREI CARVALHO SPOSITO (SP) Mechanisms linking atherosclerosis to obesity Speaker: RAUL SANTOS (SP) Impact of bariatric surgery in hypertension and heart failure Speaker: LUCIANO FERREIRA DRAGER (SP) Discussion
Coordinator: VIVIANE ZORZANELLI ROCHA GIRALDEZ (SP)
Coordinator: AMELIO FERNANDO GODOY MATOS (RJ) Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets Speaker: ANDREI CARVALHO SPOSITO (SP) Mechanisms linking atherosclerosis to obesity Speaker: RAUL SANTOS (SP) Impact of bariatric surgery in hypertension and heart failure Speaker: LUCIANO FERREIRA DRAGER (SP) Discussion
Coordinator: VIVIANE ZORZANELLI ROCHA GIRALDEZ (SP)
Coordinator: AMELIO FERNANDO GODOY MATOS (RJ) Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets Speaker: ANDREI CARVALHO SPOSITO (SP) Mechanisms linking atherosclerosis to obesity Speaker: RAUL SANTOS (SP) Impact of bariatric surgery in hypertension and heart failure Speaker: LUCIANO FERREIRA DRAGER (SP) Discussion
Coordinator: VIVIANE ZORZANELLI ROCHA GIRALDEZ (SP)
Coordinator: AMELIO FERNANDO GODOY MATOS (RJ) Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets Speaker: ANDREI CARVALHO SPOSITO (SP) Mechanisms linking atherosclerosis to obesity Speaker: RAUL SANTOS (SP) Impact of bariatric surgery in hypertension and heart failure Speaker: LUCIANO FERREIRA DRAGER (SP) Discussion
Coordinator: VIVIANE ZORZANELLI ROCHA GIRALDEZ (SP)
Coordinator: AMELIO FERNANDO GODOY MATOS (RJ) Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets Speaker: ANDREI CARVALHO SPOSITO (SP) Mechanisms linking atherosclerosis to obesity Speaker: RAUL SANTOS (SP) Impact of bariatric surgery in hypertension and heart failure Speaker: LUCIANO FERREIRA DRAGER (SP) Discussion
Coordinator: VIVIANE ZORZANELLI ROCHA GIRALDEZ (SP)
Coordinator: AMELIO FERNANDO GODOY MATOS (RJ) Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets Speaker: ANDREI CARVALHO SPOSITO (SP) Mechanisms linking atherosclerosis to obesity Speaker: RAUL SANTOS (SP) Impact of bariatric surgery in hypertension and heart failure Speaker: LUCIANO FERREIRA DRAGER (SP) Discussion |
BREAK 09:30 - 10:00 |
MAIN CONFERENCE How stigma impacts health? 10:00 - 11:00
Chair: LUIZ FELLIPE CARVALHO VIOLA (MT)
Keynote Speaker: STUART FLINT (United Kingdom) Discussion
Chair: LUIZ FELLIPE CARVALHO VIOLA (MT)
Keynote Speaker: STUART FLINT (United Kingdom) Discussion
Chair: LUIZ FELLIPE CARVALHO VIOLA (MT)
Keynote Speaker: STUART FLINT (United Kingdom) Discussion |
SESSION Sitting time and sedentarism 11:00 - 12:30
Coordinator: CLAYTON DORNELLES MACEDO (RS)
Coordinator: ROBERTO ZAGURY (RJ) Physiology of sedentarism Speaker: HAMILTON ROSCHEL (SP) Is sitting time a risk factor independent of overall physical activity? Speaker: LEANDRO FORNIAS MACHADO DE REZENDE (SP) “Exercise snacks” as an approach to reduce sedentarism and improve outcomes Speaker: BRUNO GUALANO (SP) Discussion
Coordinator: CLAYTON DORNELLES MACEDO (RS)
Coordinator: ROBERTO ZAGURY (RJ) Physiology of sedentarism Speaker: HAMILTON ROSCHEL (SP) Is sitting time a risk factor independent of overall physical activity? Speaker: LEANDRO FORNIAS MACHADO DE REZENDE (SP) “Exercise snacks” as an approach to reduce sedentarism and improve outcomes Speaker: BRUNO GUALANO (SP) Discussion
Coordinator: CLAYTON DORNELLES MACEDO (RS)
Coordinator: ROBERTO ZAGURY (RJ) Physiology of sedentarism Speaker: HAMILTON ROSCHEL (SP) Is sitting time a risk factor independent of overall physical activity? Speaker: LEANDRO FORNIAS MACHADO DE REZENDE (SP) “Exercise snacks” as an approach to reduce sedentarism and improve outcomes Speaker: BRUNO GUALANO (SP) Discussion
Coordinator: CLAYTON DORNELLES MACEDO (RS)
Coordinator: ROBERTO ZAGURY (RJ) Physiology of sedentarism Speaker: HAMILTON ROSCHEL (SP) Is sitting time a risk factor independent of overall physical activity? Speaker: LEANDRO FORNIAS MACHADO DE REZENDE (SP) “Exercise snacks” as an approach to reduce sedentarism and improve outcomes Speaker: BRUNO GUALANO (SP) Discussion
Coordinator: CLAYTON DORNELLES MACEDO (RS)
Coordinator: ROBERTO ZAGURY (RJ) Physiology of sedentarism Speaker: HAMILTON ROSCHEL (SP) Is sitting time a risk factor independent of overall physical activity? Speaker: LEANDRO FORNIAS MACHADO DE REZENDE (SP) “Exercise snacks” as an approach to reduce sedentarism and improve outcomes Speaker: BRUNO GUALANO (SP) Discussion
Coordinator: CLAYTON DORNELLES MACEDO (RS)
Coordinator: ROBERTO ZAGURY (RJ) Physiology of sedentarism Speaker: HAMILTON ROSCHEL (SP) Is sitting time a risk factor independent of overall physical activity? Speaker: LEANDRO FORNIAS MACHADO DE REZENDE (SP) “Exercise snacks” as an approach to reduce sedentarism and improve outcomes Speaker: BRUNO GUALANO (SP) Discussion |
SATELLITE SYMPOSIUM - BOEHRINGER-INGELHEIM (RESTRICTED TO PRESCRIBERS) 12:30 - 13:30
The Weight of Health: Redefining Success in Obesity Management
(RESTRICTED TO PRESCRIBERS) Moderator: CYNTHIA MELISSA VALERIO (RJ) Welcome More than Numbers: A Deeper Look at Obesity Speaker: BRUNO HALPERN (SP) The Role of the Liver: Orchestrating Metabolism and Beyond Speaker: CLAUDIA PINTO MARQUES SOUZA DE OLIVEIRA (SP) Q&A
The Weight of Health: Redefining Success in Obesity Management
(RESTRICTED TO PRESCRIBERS) Moderator: CYNTHIA MELISSA VALERIO (RJ) Welcome More than Numbers: A Deeper Look at Obesity Speaker: BRUNO HALPERN (SP) The Role of the Liver: Orchestrating Metabolism and Beyond Speaker: CLAUDIA PINTO MARQUES SOUZA DE OLIVEIRA (SP) Q&A
The Weight of Health: Redefining Success in Obesity Management
(RESTRICTED TO PRESCRIBERS) Moderator: CYNTHIA MELISSA VALERIO (RJ) Welcome More than Numbers: A Deeper Look at Obesity Speaker: BRUNO HALPERN (SP) The Role of the Liver: Orchestrating Metabolism and Beyond Speaker: CLAUDIA PINTO MARQUES SOUZA DE OLIVEIRA (SP) Q&A
The Weight of Health: Redefining Success in Obesity Management
(RESTRICTED TO PRESCRIBERS) Moderator: CYNTHIA MELISSA VALERIO (RJ) Welcome More than Numbers: A Deeper Look at Obesity Speaker: BRUNO HALPERN (SP) The Role of the Liver: Orchestrating Metabolism and Beyond Speaker: CLAUDIA PINTO MARQUES SOUZA DE OLIVEIRA (SP) Q&A
The Weight of Health: Redefining Success in Obesity Management
(RESTRICTED TO PRESCRIBERS) Moderator: CYNTHIA MELISSA VALERIO (RJ) Welcome More than Numbers: A Deeper Look at Obesity Speaker: BRUNO HALPERN (SP) The Role of the Liver: Orchestrating Metabolism and Beyond Speaker: CLAUDIA PINTO MARQUES SOUZA DE OLIVEIRA (SP) Q&A
The Weight of Health: Redefining Success in Obesity Management
(RESTRICTED TO PRESCRIBERS) Moderator: CYNTHIA MELISSA VALERIO (RJ) Welcome More than Numbers: A Deeper Look at Obesity Speaker: BRUNO HALPERN (SP) The Role of the Liver: Orchestrating Metabolism and Beyond Speaker: CLAUDIA PINTO MARQUES SOUZA DE OLIVEIRA (SP) Q&A |
ROUND TABLE Living with obesity: How stigma shaped my life and my search for treatments 14:00 - 15:30
Moderator: JOHANNA RALSTON (United Kingdom)
Debater: ERICKA CUZZIOL LIMA LUIZ (SP) Debater: AMBER HUETT-GARCIA (United States) Debater: MARIA EUGENIA ANSELMI (Argentina)
Moderator: JOHANNA RALSTON (United Kingdom)
Debater: ERICKA CUZZIOL LIMA LUIZ (SP) Debater: AMBER HUETT-GARCIA (United States) Debater: MARIA EUGENIA ANSELMI (Argentina)
Moderator: JOHANNA RALSTON (United Kingdom)
Debater: ERICKA CUZZIOL LIMA LUIZ (SP) Debater: AMBER HUETT-GARCIA (United States) Debater: MARIA EUGENIA ANSELMI (Argentina)
Moderator: JOHANNA RALSTON (United Kingdom)
Debater: ERICKA CUZZIOL LIMA LUIZ (SP) Debater: AMBER HUETT-GARCIA (United States) Debater: MARIA EUGENIA ANSELMI (Argentina) |
SESSION Obesity in the elderly: impact on mucles and bones 16:30 - 18:00
Coordinator: FÁBIO ROGERIO TRUJILHO (BA)
Coordinator: ADELA GONZÁLEZ BARNECH (Uruguay) Abstracts - 128677: HIGH-INTENSITY INTERVAL TRAINING IMPROVES CARDIOMYOCYTE CONTRACTILE FUNCTION AND INTRACELLULAR CALCIUM HANDLING IN OBESE RATS - Presenter: André Soares Leopoldo Sarcopenic obesity: emerging mechanisms and diagnosis Speaker: JOĂO EDUARDO NUNES SALLES (SP) Obesity and skeletal fragility Speaker: FRANCISCO JOSÉ A. DE PAULA (SP) Skeletal muscle and metabolic health: how do we increase muscle mass and function in people with obesity and type 2 Diabetes? Speaker: BRUNO GUALANO (SP) Discussion
Coordinator: FÁBIO ROGERIO TRUJILHO (BA)
Coordinator: ADELA GONZÁLEZ BARNECH (Uruguay) Abstracts - 128677: HIGH-INTENSITY INTERVAL TRAINING IMPROVES CARDIOMYOCYTE CONTRACTILE FUNCTION AND INTRACELLULAR CALCIUM HANDLING IN OBESE RATS - Presenter: André Soares Leopoldo Sarcopenic obesity: emerging mechanisms and diagnosis Speaker: JOĂO EDUARDO NUNES SALLES (SP) Obesity and skeletal fragility Speaker: FRANCISCO JOSÉ A. DE PAULA (SP) Skeletal muscle and metabolic health: how do we increase muscle mass and function in people with obesity and type 2 Diabetes? Speaker: BRUNO GUALANO (SP) Discussion
Coordinator: FÁBIO ROGERIO TRUJILHO (BA)
Coordinator: ADELA GONZÁLEZ BARNECH (Uruguay) Abstracts - 128677: HIGH-INTENSITY INTERVAL TRAINING IMPROVES CARDIOMYOCYTE CONTRACTILE FUNCTION AND INTRACELLULAR CALCIUM HANDLING IN OBESE RATS - Presenter: André Soares Leopoldo Sarcopenic obesity: emerging mechanisms and diagnosis Speaker: JOĂO EDUARDO NUNES SALLES (SP) Obesity and skeletal fragility Speaker: FRANCISCO JOSÉ A. DE PAULA (SP) Skeletal muscle and metabolic health: how do we increase muscle mass and function in people with obesity and type 2 Diabetes? Speaker: BRUNO GUALANO (SP) Discussion
Coordinator: FÁBIO ROGERIO TRUJILHO (BA)
Coordinator: ADELA GONZÁLEZ BARNECH (Uruguay) Abstracts - 128677: HIGH-INTENSITY INTERVAL TRAINING IMPROVES CARDIOMYOCYTE CONTRACTILE FUNCTION AND INTRACELLULAR CALCIUM HANDLING IN OBESE RATS - Presenter: André Soares Leopoldo Sarcopenic obesity: emerging mechanisms and diagnosis Speaker: JOĂO EDUARDO NUNES SALLES (SP) Obesity and skeletal fragility Speaker: FRANCISCO JOSÉ A. DE PAULA (SP) Skeletal muscle and metabolic health: how do we increase muscle mass and function in people with obesity and type 2 Diabetes? Speaker: BRUNO GUALANO (SP) Discussion
Coordinator: FÁBIO ROGERIO TRUJILHO (BA)
Coordinator: ADELA GONZÁLEZ BARNECH (Uruguay) Abstracts - 128677: HIGH-INTENSITY INTERVAL TRAINING IMPROVES CARDIOMYOCYTE CONTRACTILE FUNCTION AND INTRACELLULAR CALCIUM HANDLING IN OBESE RATS - Presenter: André Soares Leopoldo Sarcopenic obesity: emerging mechanisms and diagnosis Speaker: JOĂO EDUARDO NUNES SALLES (SP) Obesity and skeletal fragility Speaker: FRANCISCO JOSÉ A. DE PAULA (SP) Skeletal muscle and metabolic health: how do we increase muscle mass and function in people with obesity and type 2 Diabetes? Speaker: BRUNO GUALANO (SP) Discussion
Coordinator: FÁBIO ROGERIO TRUJILHO (BA)
Coordinator: ADELA GONZÁLEZ BARNECH (Uruguay) Abstracts - 128677: HIGH-INTENSITY INTERVAL TRAINING IMPROVES CARDIOMYOCYTE CONTRACTILE FUNCTION AND INTRACELLULAR CALCIUM HANDLING IN OBESE RATS - Presenter: André Soares Leopoldo Sarcopenic obesity: emerging mechanisms and diagnosis Speaker: JOĂO EDUARDO NUNES SALLES (SP) Obesity and skeletal fragility Speaker: FRANCISCO JOSÉ A. DE PAULA (SP) Skeletal muscle and metabolic health: how do we increase muscle mass and function in people with obesity and type 2 Diabetes? Speaker: BRUNO GUALANO (SP) Discussion
Coordinator: FÁBIO ROGERIO TRUJILHO (BA)
Coordinator: ADELA GONZÁLEZ BARNECH (Uruguay) Abstracts - 128677: HIGH-INTENSITY INTERVAL TRAINING IMPROVES CARDIOMYOCYTE CONTRACTILE FUNCTION AND INTRACELLULAR CALCIUM HANDLING IN OBESE RATS - Presenter: André Soares Leopoldo Sarcopenic obesity: emerging mechanisms and diagnosis Speaker: JOĂO EDUARDO NUNES SALLES (SP) Obesity and skeletal fragility Speaker: FRANCISCO JOSÉ A. DE PAULA (SP) Skeletal muscle and metabolic health: how do we increase muscle mass and function in people with obesity and type 2 Diabetes? Speaker: BRUNO GUALANO (SP) Discussion |
||||||||||||||||||||||||||||||||||||||||||
Room 3 - Bernard Jeanrenaud |
SESSION Obesity and the brain 08:00 - 09:30
Coordinator: LÍCIO VELLOSO (SP)
Abstracts - 128974: HYPOTHALAMIC CXCR3+ IMMUNE CELL RECRUITMENT PROTECTS MICE FROM HIGH-FAT DIET-INDUCED METABOLIC DYSFUNCTION. - Presenter: Natalia Ferreira Mendes The set point vs the dual intervention point models and body weight regulation Speaker: ERIC RAVUSSIN (United States) Melanocortins, obesity and the brain – unveiling myths and facts Speaker: MARCELO RUBINSTEIN (Argentina) Brain responses to nutrients in obesity and after weight loss Speaker: SIMONE VAN DE SANDE LEE (SC) Discussion
Coordinator: LÍCIO VELLOSO (SP)
Abstracts - 128974: HYPOTHALAMIC CXCR3+ IMMUNE CELL RECRUITMENT PROTECTS MICE FROM HIGH-FAT DIET-INDUCED METABOLIC DYSFUNCTION. - Presenter: Natalia Ferreira Mendes The set point vs the dual intervention point models and body weight regulation Speaker: ERIC RAVUSSIN (United States) Melanocortins, obesity and the brain – unveiling myths and facts Speaker: MARCELO RUBINSTEIN (Argentina) Brain responses to nutrients in obesity and after weight loss Speaker: SIMONE VAN DE SANDE LEE (SC) Discussion
Coordinator: LÍCIO VELLOSO (SP)
Abstracts - 128974: HYPOTHALAMIC CXCR3+ IMMUNE CELL RECRUITMENT PROTECTS MICE FROM HIGH-FAT DIET-INDUCED METABOLIC DYSFUNCTION. - Presenter: Natalia Ferreira Mendes The set point vs the dual intervention point models and body weight regulation Speaker: ERIC RAVUSSIN (United States) Melanocortins, obesity and the brain – unveiling myths and facts Speaker: MARCELO RUBINSTEIN (Argentina) Brain responses to nutrients in obesity and after weight loss Speaker: SIMONE VAN DE SANDE LEE (SC) Discussion
Coordinator: LÍCIO VELLOSO (SP)
Abstracts - 128974: HYPOTHALAMIC CXCR3+ IMMUNE CELL RECRUITMENT PROTECTS MICE FROM HIGH-FAT DIET-INDUCED METABOLIC DYSFUNCTION. - Presenter: Natalia Ferreira Mendes The set point vs the dual intervention point models and body weight regulation Speaker: ERIC RAVUSSIN (United States) Melanocortins, obesity and the brain – unveiling myths and facts Speaker: MARCELO RUBINSTEIN (Argentina) Brain responses to nutrients in obesity and after weight loss Speaker: SIMONE VAN DE SANDE LEE (SC) Discussion
Coordinator: LÍCIO VELLOSO (SP)
Abstracts - 128974: HYPOTHALAMIC CXCR3+ IMMUNE CELL RECRUITMENT PROTECTS MICE FROM HIGH-FAT DIET-INDUCED METABOLIC DYSFUNCTION. - Presenter: Natalia Ferreira Mendes The set point vs the dual intervention point models and body weight regulation Speaker: ERIC RAVUSSIN (United States) Melanocortins, obesity and the brain – unveiling myths and facts Speaker: MARCELO RUBINSTEIN (Argentina) Brain responses to nutrients in obesity and after weight loss Speaker: SIMONE VAN DE SANDE LEE (SC) Discussion
Coordinator: LÍCIO VELLOSO (SP)
Abstracts - 128974: HYPOTHALAMIC CXCR3+ IMMUNE CELL RECRUITMENT PROTECTS MICE FROM HIGH-FAT DIET-INDUCED METABOLIC DYSFUNCTION. - Presenter: Natalia Ferreira Mendes The set point vs the dual intervention point models and body weight regulation Speaker: ERIC RAVUSSIN (United States) Melanocortins, obesity and the brain – unveiling myths and facts Speaker: MARCELO RUBINSTEIN (Argentina) Brain responses to nutrients in obesity and after weight loss Speaker: SIMONE VAN DE SANDE LEE (SC) Discussion |
BREAK 09:30 - 10:00 |
KEYNOTE LECTURE The first decade of global food policy – the past and the present 10:00 - 11:00
Chairman: SIMON BARQUERA (Mexico)
Keynote Speaker: BARRY POPKIN (United States) Questions
Chairman: SIMON BARQUERA (Mexico)
Keynote Speaker: BARRY POPKIN (United States) Questions
Chairman: SIMON BARQUERA (Mexico)
Keynote Speaker: BARRY POPKIN (United States) Questions |
SYMPOSIUM Cancer and obesity 11:00 - 12:30
Coordinator: MARCELO ALVES DA SILVA MORI (SP)
Obesity as a risk factor for cancer: putative mechanisms Speaker: PHILIPP SCHERER (United States) Sex differences on the impact of obesity and its treatment on cancer outcomes Speaker: ADA CUEVAS (Chile) Lifestyle interventions to prevent cancer incidence and recurrence Speaker: FERNANDO GERCHMAN (RS) Abstract Discussion
Coordinator: MARCELO ALVES DA SILVA MORI (SP)
Obesity as a risk factor for cancer: putative mechanisms Speaker: PHILIPP SCHERER (United States) Sex differences on the impact of obesity and its treatment on cancer outcomes Speaker: ADA CUEVAS (Chile) Lifestyle interventions to prevent cancer incidence and recurrence Speaker: FERNANDO GERCHMAN (RS) Abstract Discussion
Coordinator: MARCELO ALVES DA SILVA MORI (SP)
Obesity as a risk factor for cancer: putative mechanisms Speaker: PHILIPP SCHERER (United States) Sex differences on the impact of obesity and its treatment on cancer outcomes Speaker: ADA CUEVAS (Chile) Lifestyle interventions to prevent cancer incidence and recurrence Speaker: FERNANDO GERCHMAN (RS) Abstract Discussion
Coordinator: MARCELO ALVES DA SILVA MORI (SP)
Obesity as a risk factor for cancer: putative mechanisms Speaker: PHILIPP SCHERER (United States) Sex differences on the impact of obesity and its treatment on cancer outcomes Speaker: ADA CUEVAS (Chile) Lifestyle interventions to prevent cancer incidence and recurrence Speaker: FERNANDO GERCHMAN (RS) Abstract Discussion
Coordinator: MARCELO ALVES DA SILVA MORI (SP)
Obesity as a risk factor for cancer: putative mechanisms Speaker: PHILIPP SCHERER (United States) Sex differences on the impact of obesity and its treatment on cancer outcomes Speaker: ADA CUEVAS (Chile) Lifestyle interventions to prevent cancer incidence and recurrence Speaker: FERNANDO GERCHMAN (RS) Abstract Discussion
Coordinator: MARCELO ALVES DA SILVA MORI (SP)
Obesity as a risk factor for cancer: putative mechanisms Speaker: PHILIPP SCHERER (United States) Sex differences on the impact of obesity and its treatment on cancer outcomes Speaker: ADA CUEVAS (Chile) Lifestyle interventions to prevent cancer incidence and recurrence Speaker: FERNANDO GERCHMAN (RS) Abstract Discussion
Coordinator: MARCELO ALVES DA SILVA MORI (SP)
Obesity as a risk factor for cancer: putative mechanisms Speaker: PHILIPP SCHERER (United States) Sex differences on the impact of obesity and its treatment on cancer outcomes Speaker: ADA CUEVAS (Chile) Lifestyle interventions to prevent cancer incidence and recurrence Speaker: FERNANDO GERCHMAN (RS) Abstract Discussion |
SATELLITE SYMPOSIUM - ASTRAZENECA 12:30 - 13:30
Woman, 58 years old, BMI 29, complains of fatigue: Should I consider HFpEF?
Restricted to Prescribers Speaker: ANDREI CARVALHO SPOSITO (SP)
Woman, 58 years old, BMI 29, complains of fatigue: Should I consider HFpEF?
Restricted to Prescribers Speaker: ANDREI CARVALHO SPOSITO (SP) |
SESSION Neuroscience on diets 14:00 - 15:30
Coordinator: MARIO JOSÉ ABDALLA SAAD (SP)
Coordinator: RAFAEL FIGUEIREDO (Paraguay) Abstracts - 128922: IPREVENT: INCREASING COLONIC PROPIONATE FOR THE PREVENTION OF WEIGHT GAIN IN YOUNGER ADULTS, A 12-MONTH RANDOMISED CONTROLLED TRIAL. - Presenter: Jennifer Pugh Ketones and the brain: myths, facts and presumptions Speaker: MARCIO ALBERTO TORSONI (SP) Artificial sweeteners and brain response Speaker: GABRIEL ANHE (SP) Saturated/Unsaturated fat and brain inflammation Speaker: LÍCIO VELLOSO (SP) Discussion
Coordinator: MARIO JOSÉ ABDALLA SAAD (SP)
Coordinator: RAFAEL FIGUEIREDO (Paraguay) Abstracts - 128922: IPREVENT: INCREASING COLONIC PROPIONATE FOR THE PREVENTION OF WEIGHT GAIN IN YOUNGER ADULTS, A 12-MONTH RANDOMISED CONTROLLED TRIAL. - Presenter: Jennifer Pugh Ketones and the brain: myths, facts and presumptions Speaker: MARCIO ALBERTO TORSONI (SP) Artificial sweeteners and brain response Speaker: GABRIEL ANHE (SP) Saturated/Unsaturated fat and brain inflammation Speaker: LÍCIO VELLOSO (SP) Discussion
Coordinator: MARIO JOSÉ ABDALLA SAAD (SP)
Coordinator: RAFAEL FIGUEIREDO (Paraguay) Abstracts - 128922: IPREVENT: INCREASING COLONIC PROPIONATE FOR THE PREVENTION OF WEIGHT GAIN IN YOUNGER ADULTS, A 12-MONTH RANDOMISED CONTROLLED TRIAL. - Presenter: Jennifer Pugh Ketones and the brain: myths, facts and presumptions Speaker: MARCIO ALBERTO TORSONI (SP) Artificial sweeteners and brain response Speaker: GABRIEL ANHE (SP) Saturated/Unsaturated fat and brain inflammation Speaker: LÍCIO VELLOSO (SP) Discussion
Coordinator: MARIO JOSÉ ABDALLA SAAD (SP)
Coordinator: RAFAEL FIGUEIREDO (Paraguay) Abstracts - 128922: IPREVENT: INCREASING COLONIC PROPIONATE FOR THE PREVENTION OF WEIGHT GAIN IN YOUNGER ADULTS, A 12-MONTH RANDOMISED CONTROLLED TRIAL. - Presenter: Jennifer Pugh Ketones and the brain: myths, facts and presumptions Speaker: MARCIO ALBERTO TORSONI (SP) Artificial sweeteners and brain response Speaker: GABRIEL ANHE (SP) Saturated/Unsaturated fat and brain inflammation Speaker: LÍCIO VELLOSO (SP) Discussion
Coordinator: MARIO JOSÉ ABDALLA SAAD (SP)
Coordinator: RAFAEL FIGUEIREDO (Paraguay) Abstracts - 128922: IPREVENT: INCREASING COLONIC PROPIONATE FOR THE PREVENTION OF WEIGHT GAIN IN YOUNGER ADULTS, A 12-MONTH RANDOMISED CONTROLLED TRIAL. - Presenter: Jennifer Pugh Ketones and the brain: myths, facts and presumptions Speaker: MARCIO ALBERTO TORSONI (SP) Artificial sweeteners and brain response Speaker: GABRIEL ANHE (SP) Saturated/Unsaturated fat and brain inflammation Speaker: LÍCIO VELLOSO (SP) Discussion
Coordinator: MARIO JOSÉ ABDALLA SAAD (SP)
Coordinator: RAFAEL FIGUEIREDO (Paraguay) Abstracts - 128922: IPREVENT: INCREASING COLONIC PROPIONATE FOR THE PREVENTION OF WEIGHT GAIN IN YOUNGER ADULTS, A 12-MONTH RANDOMISED CONTROLLED TRIAL. - Presenter: Jennifer Pugh Ketones and the brain: myths, facts and presumptions Speaker: MARCIO ALBERTO TORSONI (SP) Artificial sweeteners and brain response Speaker: GABRIEL ANHE (SP) Saturated/Unsaturated fat and brain inflammation Speaker: LÍCIO VELLOSO (SP) Discussion
Coordinator: MARIO JOSÉ ABDALLA SAAD (SP)
Coordinator: RAFAEL FIGUEIREDO (Paraguay) Abstracts - 128922: IPREVENT: INCREASING COLONIC PROPIONATE FOR THE PREVENTION OF WEIGHT GAIN IN YOUNGER ADULTS, A 12-MONTH RANDOMISED CONTROLLED TRIAL. - Presenter: Jennifer Pugh Ketones and the brain: myths, facts and presumptions Speaker: MARCIO ALBERTO TORSONI (SP) Artificial sweeteners and brain response Speaker: GABRIEL ANHE (SP) Saturated/Unsaturated fat and brain inflammation Speaker: LÍCIO VELLOSO (SP) Discussion |
REFRESHMENT BREAK AND POSTER SESSION 15:30 - 16:30 |
MEET THE EXPERT Binge eating disorder – from diagnosis to long term management 16:30 - 17:30
Coordinator: TÁKI ATHANÁSSIOS CORDÁZ (SP)
Speaker: JOSE CARLOS APPOLINARIO (RJ)
Coordinator: TÁKI ATHANÁSSIOS CORDÁZ (SP)
Speaker: JOSE CARLOS APPOLINARIO (RJ) |
MEET THE EXPERT Measuring body composition on clinical practice: how to use BIA, DXA and others 17:30 - 18:30
Coordinator: ROBERTO ZAGURY (RJ)
Speaker: GUILHERME ARTIOLI (SP)
Coordinator: ROBERTO ZAGURY (RJ)
Speaker: GUILHERME ARTIOLI (SP) |
||||||||||||||||||||||||||||||||||||||||
Room 4 - Peter Kopelman |
SYMPOSIUM SBD-ABESO - Obesity and type 2 diabetes 08:00 - 09:30
Coordinator: MARIA EDNA DE MELO (SP)
Coordinator: JACQUELINE RIZZOLLI (RS) Obesity and weight management for prevention of T2DM Speaker: JOĂO EDUARDO NUNES SALLES (SP) MASH in diabetes: should we be worried about liver or cardiovascular outcomes? Speaker: RODRIGO NUNES LAMOUNIER (MG) Remission of diabetes with clinical weight loss: a viable approach? Speaker: FERNANDO VALENTE (SP) Metabolic surgery in T2D: unraveling the role of WL in T2D improvement and remission Speaker: MARCIO C. MANCINI (SP) Discussion
Coordinator: MARIA EDNA DE MELO (SP)
Coordinator: JACQUELINE RIZZOLLI (RS) Obesity and weight management for prevention of T2DM Speaker: JOĂO EDUARDO NUNES SALLES (SP) MASH in diabetes: should we be worried about liver or cardiovascular outcomes? Speaker: RODRIGO NUNES LAMOUNIER (MG) Remission of diabetes with clinical weight loss: a viable approach? Speaker: FERNANDO VALENTE (SP) Metabolic surgery in T2D: unraveling the role of WL in T2D improvement and remission Speaker: MARCIO C. MANCINI (SP) Discussion
Coordinator: MARIA EDNA DE MELO (SP)
Coordinator: JACQUELINE RIZZOLLI (RS) Obesity and weight management for prevention of T2DM Speaker: JOĂO EDUARDO NUNES SALLES (SP) MASH in diabetes: should we be worried about liver or cardiovascular outcomes? Speaker: RODRIGO NUNES LAMOUNIER (MG) Remission of diabetes with clinical weight loss: a viable approach? Speaker: FERNANDO VALENTE (SP) Metabolic surgery in T2D: unraveling the role of WL in T2D improvement and remission Speaker: MARCIO C. MANCINI (SP) Discussion
Coordinator: MARIA EDNA DE MELO (SP)
Coordinator: JACQUELINE RIZZOLLI (RS) Obesity and weight management for prevention of T2DM Speaker: JOĂO EDUARDO NUNES SALLES (SP) MASH in diabetes: should we be worried about liver or cardiovascular outcomes? Speaker: RODRIGO NUNES LAMOUNIER (MG) Remission of diabetes with clinical weight loss: a viable approach? Speaker: FERNANDO VALENTE (SP) Metabolic surgery in T2D: unraveling the role of WL in T2D improvement and remission Speaker: MARCIO C. MANCINI (SP) Discussion
Coordinator: MARIA EDNA DE MELO (SP)
Coordinator: JACQUELINE RIZZOLLI (RS) Obesity and weight management for prevention of T2DM Speaker: JOĂO EDUARDO NUNES SALLES (SP) MASH in diabetes: should we be worried about liver or cardiovascular outcomes? Speaker: RODRIGO NUNES LAMOUNIER (MG) Remission of diabetes with clinical weight loss: a viable approach? Speaker: FERNANDO VALENTE (SP) Metabolic surgery in T2D: unraveling the role of WL in T2D improvement and remission Speaker: MARCIO C. MANCINI (SP) Discussion
Coordinator: MARIA EDNA DE MELO (SP)
Coordinator: JACQUELINE RIZZOLLI (RS) Obesity and weight management for prevention of T2DM Speaker: JOĂO EDUARDO NUNES SALLES (SP) MASH in diabetes: should we be worried about liver or cardiovascular outcomes? Speaker: RODRIGO NUNES LAMOUNIER (MG) Remission of diabetes with clinical weight loss: a viable approach? Speaker: FERNANDO VALENTE (SP) Metabolic surgery in T2D: unraveling the role of WL in T2D improvement and remission Speaker: MARCIO C. MANCINI (SP) Discussion
Coordinator: MARIA EDNA DE MELO (SP)
Coordinator: JACQUELINE RIZZOLLI (RS) Obesity and weight management for prevention of T2DM Speaker: JOĂO EDUARDO NUNES SALLES (SP) MASH in diabetes: should we be worried about liver or cardiovascular outcomes? Speaker: RODRIGO NUNES LAMOUNIER (MG) Remission of diabetes with clinical weight loss: a viable approach? Speaker: FERNANDO VALENTE (SP) Metabolic surgery in T2D: unraveling the role of WL in T2D improvement and remission Speaker: MARCIO C. MANCINI (SP) Discussion |
SYMPOSIUM Other ways to look into obesity 09:30 - 10:30
Coordinator: PAULO AUGUSTO CARVALHO MIRANDA (MG)
Weight trajectory and maximum weight in life as a key information in obesity treatment: a proposal by ABESO/SBEM Speaker: BRUNO HALPERN (SP) Edmonton Obesity Staging System – what´s new? Speaker: ARYA SHARMA (Canada) Discussion
Coordinator: PAULO AUGUSTO CARVALHO MIRANDA (MG)
Weight trajectory and maximum weight in life as a key information in obesity treatment: a proposal by ABESO/SBEM Speaker: BRUNO HALPERN (SP) Edmonton Obesity Staging System – what´s new? Speaker: ARYA SHARMA (Canada) Discussion
Coordinator: PAULO AUGUSTO CARVALHO MIRANDA (MG)
Weight trajectory and maximum weight in life as a key information in obesity treatment: a proposal by ABESO/SBEM Speaker: BRUNO HALPERN (SP) Edmonton Obesity Staging System – what´s new? Speaker: ARYA SHARMA (Canada) Discussion
Coordinator: PAULO AUGUSTO CARVALHO MIRANDA (MG)
Weight trajectory and maximum weight in life as a key information in obesity treatment: a proposal by ABESO/SBEM Speaker: BRUNO HALPERN (SP) Edmonton Obesity Staging System – what´s new? Speaker: ARYA SHARMA (Canada) Discussion |
BREAK 10:30 - 11:00 |
SESSION Surmount-OSA Trial Results: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity 11:00 - 12:30
Moderator: LUCIANO FERREIRA DRAGER (SP)
Moderator: BRUNO HALPERN (SP) Obesity and Obstructive Sleep Apnea – Setting the scene Speaker: DENISE FRANCO (SP) OSA: clinical characteristics and current therapeutic landscape Speaker: LUCIANO FERREIRA DRAGER (SP) Surmont-OSA: study design and results Speaker: RICHARD SCHWAB Panel Discussion: Putting Surmount-OSA results in context and its implications to clinical care
Moderator: LUCIANO FERREIRA DRAGER (SP)
Moderator: BRUNO HALPERN (SP) Obesity and Obstructive Sleep Apnea – Setting the scene Speaker: DENISE FRANCO (SP) OSA: clinical characteristics and current therapeutic landscape Speaker: LUCIANO FERREIRA DRAGER (SP) Surmont-OSA: study design and results Speaker: RICHARD SCHWAB Panel Discussion: Putting Surmount-OSA results in context and its implications to clinical care
Moderator: LUCIANO FERREIRA DRAGER (SP)
Moderator: BRUNO HALPERN (SP) Obesity and Obstructive Sleep Apnea – Setting the scene Speaker: DENISE FRANCO (SP) OSA: clinical characteristics and current therapeutic landscape Speaker: LUCIANO FERREIRA DRAGER (SP) Surmont-OSA: study design and results Speaker: RICHARD SCHWAB Panel Discussion: Putting Surmount-OSA results in context and its implications to clinical care
Moderator: LUCIANO FERREIRA DRAGER (SP)
Moderator: BRUNO HALPERN (SP) Obesity and Obstructive Sleep Apnea – Setting the scene Speaker: DENISE FRANCO (SP) OSA: clinical characteristics and current therapeutic landscape Speaker: LUCIANO FERREIRA DRAGER (SP) Surmont-OSA: study design and results Speaker: RICHARD SCHWAB Panel Discussion: Putting Surmount-OSA results in context and its implications to clinical care
Moderator: LUCIANO FERREIRA DRAGER (SP)
Moderator: BRUNO HALPERN (SP) Obesity and Obstructive Sleep Apnea – Setting the scene Speaker: DENISE FRANCO (SP) OSA: clinical characteristics and current therapeutic landscape Speaker: LUCIANO FERREIRA DRAGER (SP) Surmont-OSA: study design and results Speaker: RICHARD SCHWAB Panel Discussion: Putting Surmount-OSA results in context and its implications to clinical care
Moderator: LUCIANO FERREIRA DRAGER (SP)
Moderator: BRUNO HALPERN (SP) Obesity and Obstructive Sleep Apnea – Setting the scene Speaker: DENISE FRANCO (SP) OSA: clinical characteristics and current therapeutic landscape Speaker: LUCIANO FERREIRA DRAGER (SP) Surmont-OSA: study design and results Speaker: RICHARD SCHWAB Panel Discussion: Putting Surmount-OSA results in context and its implications to clinical care |
SATELLITE SYMPOSIUM - TAKEDA 12:30 - 13:30
Treatment of Eating Disorders in Patients with Obesity: What is the Best Approach for Different Patient Profiles?
Speaker: ADRIANO SEGAL Speaker: PRISCILLA GIL
Treatment of Eating Disorders in Patients with Obesity: What is the Best Approach for Different Patient Profiles?
Speaker: ADRIANO SEGAL Speaker: PRISCILLA GIL
Treatment of Eating Disorders in Patients with Obesity: What is the Best Approach for Different Patient Profiles?
Speaker: ADRIANO SEGAL Speaker: PRISCILLA GIL |
SESSION Epigenetics of obesity 14:00 - 15:30
Coordinator: MARIA EDNA DE MELO (SP)
The intra-uterine environment and long term offspring risks Speaker: JOSE DONATO JUNIOR (SP) Father obesity and lifestyle factors and offspring risks Speaker: ADRIANA SOUZA TORSONI (SP) Breastfeeding and Its Impacts on Offspring and Mother: Long-Term Clinical-Epidemiological Evidence Speaker: BIANCA DE ALMEIDA PITITTO (SP) Discussion
Coordinator: MARIA EDNA DE MELO (SP)
The intra-uterine environment and long term offspring risks Speaker: JOSE DONATO JUNIOR (SP) Father obesity and lifestyle factors and offspring risks Speaker: ADRIANA SOUZA TORSONI (SP) Breastfeeding and Its Impacts on Offspring and Mother: Long-Term Clinical-Epidemiological Evidence Speaker: BIANCA DE ALMEIDA PITITTO (SP) Discussion
Coordinator: MARIA EDNA DE MELO (SP)
The intra-uterine environment and long term offspring risks Speaker: JOSE DONATO JUNIOR (SP) Father obesity and lifestyle factors and offspring risks Speaker: ADRIANA SOUZA TORSONI (SP) Breastfeeding and Its Impacts on Offspring and Mother: Long-Term Clinical-Epidemiological Evidence Speaker: BIANCA DE ALMEIDA PITITTO (SP) Discussion
Coordinator: MARIA EDNA DE MELO (SP)
The intra-uterine environment and long term offspring risks Speaker: JOSE DONATO JUNIOR (SP) Father obesity and lifestyle factors and offspring risks Speaker: ADRIANA SOUZA TORSONI (SP) Breastfeeding and Its Impacts on Offspring and Mother: Long-Term Clinical-Epidemiological Evidence Speaker: BIANCA DE ALMEIDA PITITTO (SP) Discussion
Coordinator: MARIA EDNA DE MELO (SP)
The intra-uterine environment and long term offspring risks Speaker: JOSE DONATO JUNIOR (SP) Father obesity and lifestyle factors and offspring risks Speaker: ADRIANA SOUZA TORSONI (SP) Breastfeeding and Its Impacts on Offspring and Mother: Long-Term Clinical-Epidemiological Evidence Speaker: BIANCA DE ALMEIDA PITITTO (SP) Discussion |
REFRESHMENT BREAK AND POSTER SESSION 15:30 - 16:30 |
IDF/WOF JOINT SYMPOSIUM International Diabetes Federation Position Statement for the diagnosis of intermediate hyperglycemia and Type 2 Diabetes 16:30 - 18:00
Coordinator: LOUISE BAUR (Australia)
Coordinator: HERMELINDA PEDROSA (DF) Introduction remarks - WOF and IDF Chairs The IDF new Position Statement: novel criteria for the diagnosis of Diabetes Speaker: AKTHAR HUSSAIN (Norway) Rationale for the IDF Task Force recommendations for the diagnosis of IH and Type 2 diabetes Speaker: MARIA INES SCHMIDT (RS) Implications of the recommendation for the prevention and management of obesity/diabetes and its complications Speaker: MARIA EDNA DE MELO (SP) Discussion
Coordinator: LOUISE BAUR (Australia)
Coordinator: HERMELINDA PEDROSA (DF) Introduction remarks - WOF and IDF Chairs The IDF new Position Statement: novel criteria for the diagnosis of Diabetes Speaker: AKTHAR HUSSAIN (Norway) Rationale for the IDF Task Force recommendations for the diagnosis of IH and Type 2 diabetes Speaker: MARIA INES SCHMIDT (RS) Implications of the recommendation for the prevention and management of obesity/diabetes and its complications Speaker: MARIA EDNA DE MELO (SP) Discussion
Coordinator: LOUISE BAUR (Australia)
Coordinator: HERMELINDA PEDROSA (DF) Introduction remarks - WOF and IDF Chairs The IDF new Position Statement: novel criteria for the diagnosis of Diabetes Speaker: AKTHAR HUSSAIN (Norway) Rationale for the IDF Task Force recommendations for the diagnosis of IH and Type 2 diabetes Speaker: MARIA INES SCHMIDT (RS) Implications of the recommendation for the prevention and management of obesity/diabetes and its complications Speaker: MARIA EDNA DE MELO (SP) Discussion
Coordinator: LOUISE BAUR (Australia)
Coordinator: HERMELINDA PEDROSA (DF) Introduction remarks - WOF and IDF Chairs The IDF new Position Statement: novel criteria for the diagnosis of Diabetes Speaker: AKTHAR HUSSAIN (Norway) Rationale for the IDF Task Force recommendations for the diagnosis of IH and Type 2 diabetes Speaker: MARIA INES SCHMIDT (RS) Implications of the recommendation for the prevention and management of obesity/diabetes and its complications Speaker: MARIA EDNA DE MELO (SP) Discussion
Coordinator: LOUISE BAUR (Australia)
Coordinator: HERMELINDA PEDROSA (DF) Introduction remarks - WOF and IDF Chairs The IDF new Position Statement: novel criteria for the diagnosis of Diabetes Speaker: AKTHAR HUSSAIN (Norway) Rationale for the IDF Task Force recommendations for the diagnosis of IH and Type 2 diabetes Speaker: MARIA INES SCHMIDT (RS) Implications of the recommendation for the prevention and management of obesity/diabetes and its complications Speaker: MARIA EDNA DE MELO (SP) Discussion
Coordinator: LOUISE BAUR (Australia)
Coordinator: HERMELINDA PEDROSA (DF) Introduction remarks - WOF and IDF Chairs The IDF new Position Statement: novel criteria for the diagnosis of Diabetes Speaker: AKTHAR HUSSAIN (Norway) Rationale for the IDF Task Force recommendations for the diagnosis of IH and Type 2 diabetes Speaker: MARIA INES SCHMIDT (RS) Implications of the recommendation for the prevention and management of obesity/diabetes and its complications Speaker: MARIA EDNA DE MELO (SP) Discussion
Coordinator: LOUISE BAUR (Australia)
Coordinator: HERMELINDA PEDROSA (DF) Introduction remarks - WOF and IDF Chairs The IDF new Position Statement: novel criteria for the diagnosis of Diabetes Speaker: AKTHAR HUSSAIN (Norway) Rationale for the IDF Task Force recommendations for the diagnosis of IH and Type 2 diabetes Speaker: MARIA INES SCHMIDT (RS) Implications of the recommendation for the prevention and management of obesity/diabetes and its complications Speaker: MARIA EDNA DE MELO (SP) Discussion |
|||||||||||||||||||||||||||||||||||||||||
Room 5 - Phillip James |
SESSION Commercial determinants of health - from tobacco and alcohol to SSB and UPFs industry 08:00 - 09:30
Chair: SIMON BARQUERA (Mexico)
Speaker: PAULA JOHNS (RJ) Speaker: MARIAN LORENA IBARRA AVILA (Colombia) Speaker: LAÍS AMARAL MAIS (SP) Speaker: DIEGO RODRIGUEZ SENDOYA (Uruguay/Montevideo) Discussion
Chair: SIMON BARQUERA (Mexico)
Speaker: PAULA JOHNS (RJ) Speaker: MARIAN LORENA IBARRA AVILA (Colombia) Speaker: LAÍS AMARAL MAIS (SP) Speaker: DIEGO RODRIGUEZ SENDOYA (Uruguay/Montevideo) Discussion
Chair: SIMON BARQUERA (Mexico)
Speaker: PAULA JOHNS (RJ) Speaker: MARIAN LORENA IBARRA AVILA (Colombia) Speaker: LAÍS AMARAL MAIS (SP) Speaker: DIEGO RODRIGUEZ SENDOYA (Uruguay/Montevideo) Discussion
Chair: SIMON BARQUERA (Mexico)
Speaker: PAULA JOHNS (RJ) Speaker: MARIAN LORENA IBARRA AVILA (Colombia) Speaker: LAÍS AMARAL MAIS (SP) Speaker: DIEGO RODRIGUEZ SENDOYA (Uruguay/Montevideo) Discussion
Chair: SIMON BARQUERA (Mexico)
Speaker: PAULA JOHNS (RJ) Speaker: MARIAN LORENA IBARRA AVILA (Colombia) Speaker: LAÍS AMARAL MAIS (SP) Speaker: DIEGO RODRIGUEZ SENDOYA (Uruguay/Montevideo) Discussion
Chair: SIMON BARQUERA (Mexico)
Speaker: PAULA JOHNS (RJ) Speaker: MARIAN LORENA IBARRA AVILA (Colombia) Speaker: LAÍS AMARAL MAIS (SP) Speaker: DIEGO RODRIGUEZ SENDOYA (Uruguay/Montevideo) Discussion |
SESSION Economic impact of obesity 09:30 - 10:30
Coordinator: LUIS FERNANDO VILLAÇA MEYER (SP)
Forecasting the costs and the economic impacts of public policies on overweight and obesity in Brazil Speaker: EDUARDO AUGUSTO FERNANDES NILSON (DF) The Economic Burden of Obesity in Brazil Speaker: LEANDRO FORNIAS MACHADO DE REZENDE (SP) Health and economic costs of different Canadian policies to address obesity and NCDs Speaker: MARY R. L‘ABBÉ (Canada)
Coordinator: LUIS FERNANDO VILLAÇA MEYER (SP)
Forecasting the costs and the economic impacts of public policies on overweight and obesity in Brazil Speaker: EDUARDO AUGUSTO FERNANDES NILSON (DF) The Economic Burden of Obesity in Brazil Speaker: LEANDRO FORNIAS MACHADO DE REZENDE (SP) Health and economic costs of different Canadian policies to address obesity and NCDs Speaker: MARY R. L‘ABBÉ (Canada)
Coordinator: LUIS FERNANDO VILLAÇA MEYER (SP)
Forecasting the costs and the economic impacts of public policies on overweight and obesity in Brazil Speaker: EDUARDO AUGUSTO FERNANDES NILSON (DF) The Economic Burden of Obesity in Brazil Speaker: LEANDRO FORNIAS MACHADO DE REZENDE (SP) Health and economic costs of different Canadian policies to address obesity and NCDs Speaker: MARY R. L‘ABBÉ (Canada)
Coordinator: LUIS FERNANDO VILLAÇA MEYER (SP)
Forecasting the costs and the economic impacts of public policies on overweight and obesity in Brazil Speaker: EDUARDO AUGUSTO FERNANDES NILSON (DF) The Economic Burden of Obesity in Brazil Speaker: LEANDRO FORNIAS MACHADO DE REZENDE (SP) Health and economic costs of different Canadian policies to address obesity and NCDs Speaker: MARY R. L‘ABBÉ (Canada) |
BREAK 10:30 - 11:00 |
SESSION Addressing rights, inequality, gender, race and social determinants of health 11:00 - 12:30
Moderator: KELLY GARTON (New Zealand)
Abstracts - 129059: ASSOCIATION BETWEEN OBESITY AND THE INTERSECTION OF DEPRESSION, GENDER, AND RACE IN BRAZILIAN ADULTS - Presenter: Taciana Maia de Sousa Speaker: ISABEL BARBOSA (United States) Discussion Panel : ISABEL BARBOSA (United States) : ERICKA CUZZIOL LIMA LUIZ (SP) Debater: PIERRE COOKE (Barbados) : NZAMA MBALATI (South Africa)
Moderator: KELLY GARTON (New Zealand)
Abstracts - 129059: ASSOCIATION BETWEEN OBESITY AND THE INTERSECTION OF DEPRESSION, GENDER, AND RACE IN BRAZILIAN ADULTS - Presenter: Taciana Maia de Sousa Speaker: ISABEL BARBOSA (United States) Discussion Panel : ISABEL BARBOSA (United States) : ERICKA CUZZIOL LIMA LUIZ (SP) Debater: PIERRE COOKE (Barbados) : NZAMA MBALATI (South Africa)
Moderator: KELLY GARTON (New Zealand)
Abstracts - 129059: ASSOCIATION BETWEEN OBESITY AND THE INTERSECTION OF DEPRESSION, GENDER, AND RACE IN BRAZILIAN ADULTS - Presenter: Taciana Maia de Sousa Speaker: ISABEL BARBOSA (United States) Discussion Panel : ISABEL BARBOSA (United States) : ERICKA CUZZIOL LIMA LUIZ (SP) Debater: PIERRE COOKE (Barbados) : NZAMA MBALATI (South Africa)
Moderator: KELLY GARTON (New Zealand)
Abstracts - 129059: ASSOCIATION BETWEEN OBESITY AND THE INTERSECTION OF DEPRESSION, GENDER, AND RACE IN BRAZILIAN ADULTS - Presenter: Taciana Maia de Sousa Speaker: ISABEL BARBOSA (United States) Discussion Panel : ISABEL BARBOSA (United States) : ERICKA CUZZIOL LIMA LUIZ (SP) Debater: PIERRE COOKE (Barbados) : NZAMA MBALATI (South Africa)
Moderator: KELLY GARTON (New Zealand)
Abstracts - 129059: ASSOCIATION BETWEEN OBESITY AND THE INTERSECTION OF DEPRESSION, GENDER, AND RACE IN BRAZILIAN ADULTS - Presenter: Taciana Maia de Sousa Speaker: ISABEL BARBOSA (United States) Discussion Panel : ISABEL BARBOSA (United States) : ERICKA CUZZIOL LIMA LUIZ (SP) Debater: PIERRE COOKE (Barbados) : NZAMA MBALATI (South Africa)
Moderator: KELLY GARTON (New Zealand)
Abstracts - 129059: ASSOCIATION BETWEEN OBESITY AND THE INTERSECTION OF DEPRESSION, GENDER, AND RACE IN BRAZILIAN ADULTS - Presenter: Taciana Maia de Sousa Speaker: ISABEL BARBOSA (United States) Discussion Panel : ISABEL BARBOSA (United States) : ERICKA CUZZIOL LIMA LUIZ (SP) Debater: PIERRE COOKE (Barbados) : NZAMA MBALATI (South Africa)
Moderator: KELLY GARTON (New Zealand)
Abstracts - 129059: ASSOCIATION BETWEEN OBESITY AND THE INTERSECTION OF DEPRESSION, GENDER, AND RACE IN BRAZILIAN ADULTS - Presenter: Taciana Maia de Sousa Speaker: ISABEL BARBOSA (United States) Discussion Panel : ISABEL BARBOSA (United States) : ERICKA CUZZIOL LIMA LUIZ (SP) Debater: PIERRE COOKE (Barbados) : NZAMA MBALATI (South Africa)
Moderator: KELLY GARTON (New Zealand)
Abstracts - 129059: ASSOCIATION BETWEEN OBESITY AND THE INTERSECTION OF DEPRESSION, GENDER, AND RACE IN BRAZILIAN ADULTS - Presenter: Taciana Maia de Sousa Speaker: ISABEL BARBOSA (United States) Discussion Panel : ISABEL BARBOSA (United States) : ERICKA CUZZIOL LIMA LUIZ (SP) Debater: PIERRE COOKE (Barbados) : NZAMA MBALATI (South Africa) |
SATELLITE SYMPOSIUM - EMS 12:30 - 13:30
The Future of Obesity Treatment: Progress Driven by New Technologies and Solutions. Artificial Intelligence and Its Perspectives
Moderator: CHRISTINA ECCLISSATO Speaker: WALMIR COUTINHO
The Future of Obesity Treatment: Progress Driven by New Technologies and Solutions. Artificial Intelligence and Its Perspectives
Moderator: CHRISTINA ECCLISSATO Speaker: WALMIR COUTINHO
The Future of Obesity Treatment: Progress Driven by New Technologies and Solutions. Artificial Intelligence and Its Perspectives
Moderator: CHRISTINA ECCLISSATO Speaker: WALMIR COUTINHO |
SESSION Fiscal measures for tackling malnutrition in all its forms 14:00 - 15:00
Moderator: PAULA JOHNS (RJ)
Brazilian Tax Reform- Civil Society advocating for health and sustainable diets Speaker: MARILIA SOBRAL ALBIERO The new basic basket and fiscal policies in Brazil Speaker: GISELE BORTOLINI (DF)
Moderator: PAULA JOHNS (RJ)
Brazilian Tax Reform- Civil Society advocating for health and sustainable diets Speaker: MARILIA SOBRAL ALBIERO The new basic basket and fiscal policies in Brazil Speaker: GISELE BORTOLINI (DF)
Moderator: PAULA JOHNS (RJ)
Brazilian Tax Reform- Civil Society advocating for health and sustainable diets Speaker: MARILIA SOBRAL ALBIERO The new basic basket and fiscal policies in Brazil Speaker: GISELE BORTOLINI (DF) |
SESSION Abstracts 15:00 - 15:30
: PAULA JOHNS (RJ)
Abstract - 128988: INCIDENT CASES AND DEATHS ATTRIBUTABLE TO OVERWEIGHT AND OBESITY IN BRAZIL UNTIL 2044 Abstract - 128689: ASSOCIATION OF THE COST WITH THE ENVIRONMENTAL IMPACT OF THE CURRENT AS WELL AS HEALTHY AND SUSTAINABLE DIETS IN BRAZIL Abstract - 129731: THE GLOBAL DIET QUALITY SCORE, COMPARED TO OTHER HEALTHY DIET METRICS, AND TYPE 2 DIABETES RISK - ELSA-BRASIL COHORT STUDY Abstract - 129050: NUTRITIONAL STATUS, FOOD CONSUMPTION, AND ENVIRONMENTS OF CHILDREN IN CITIES ENGAGED IN OBESITY PREVENTION IN SĂO PAULO, BRAZIL
: PAULA JOHNS (RJ)
Abstract - 128988: INCIDENT CASES AND DEATHS ATTRIBUTABLE TO OVERWEIGHT AND OBESITY IN BRAZIL UNTIL 2044 Abstract - 128689: ASSOCIATION OF THE COST WITH THE ENVIRONMENTAL IMPACT OF THE CURRENT AS WELL AS HEALTHY AND SUSTAINABLE DIETS IN BRAZIL Abstract - 129731: THE GLOBAL DIET QUALITY SCORE, COMPARED TO OTHER HEALTHY DIET METRICS, AND TYPE 2 DIABETES RISK - ELSA-BRASIL COHORT STUDY Abstract - 129050: NUTRITIONAL STATUS, FOOD CONSUMPTION, AND ENVIRONMENTS OF CHILDREN IN CITIES ENGAGED IN OBESITY PREVENTION IN SĂO PAULO, BRAZIL
: PAULA JOHNS (RJ)
Abstract - 128988: INCIDENT CASES AND DEATHS ATTRIBUTABLE TO OVERWEIGHT AND OBESITY IN BRAZIL UNTIL 2044 Abstract - 128689: ASSOCIATION OF THE COST WITH THE ENVIRONMENTAL IMPACT OF THE CURRENT AS WELL AS HEALTHY AND SUSTAINABLE DIETS IN BRAZIL Abstract - 129731: THE GLOBAL DIET QUALITY SCORE, COMPARED TO OTHER HEALTHY DIET METRICS, AND TYPE 2 DIABETES RISK - ELSA-BRASIL COHORT STUDY Abstract - 129050: NUTRITIONAL STATUS, FOOD CONSUMPTION, AND ENVIRONMENTS OF CHILDREN IN CITIES ENGAGED IN OBESITY PREVENTION IN SĂO PAULO, BRAZIL
: PAULA JOHNS (RJ)
Abstract - 128988: INCIDENT CASES AND DEATHS ATTRIBUTABLE TO OVERWEIGHT AND OBESITY IN BRAZIL UNTIL 2044 Abstract - 128689: ASSOCIATION OF THE COST WITH THE ENVIRONMENTAL IMPACT OF THE CURRENT AS WELL AS HEALTHY AND SUSTAINABLE DIETS IN BRAZIL Abstract - 129731: THE GLOBAL DIET QUALITY SCORE, COMPARED TO OTHER HEALTHY DIET METRICS, AND TYPE 2 DIABETES RISK - ELSA-BRASIL COHORT STUDY Abstract - 129050: NUTRITIONAL STATUS, FOOD CONSUMPTION, AND ENVIRONMENTS OF CHILDREN IN CITIES ENGAGED IN OBESITY PREVENTION IN SĂO PAULO, BRAZIL
: PAULA JOHNS (RJ)
Abstract - 128988: INCIDENT CASES AND DEATHS ATTRIBUTABLE TO OVERWEIGHT AND OBESITY IN BRAZIL UNTIL 2044 Abstract - 128689: ASSOCIATION OF THE COST WITH THE ENVIRONMENTAL IMPACT OF THE CURRENT AS WELL AS HEALTHY AND SUSTAINABLE DIETS IN BRAZIL Abstract - 129731: THE GLOBAL DIET QUALITY SCORE, COMPARED TO OTHER HEALTHY DIET METRICS, AND TYPE 2 DIABETES RISK - ELSA-BRASIL COHORT STUDY Abstract - 129050: NUTRITIONAL STATUS, FOOD CONSUMPTION, AND ENVIRONMENTS OF CHILDREN IN CITIES ENGAGED IN OBESITY PREVENTION IN SĂO PAULO, BRAZIL |
REFRESHMENT BREAK AND POSTER SESSION 15:30 - 16:30 |
SESSION Abstracts - Public Health 1 16:30 - 18:30
Judge: KELLY GARTON (New Zealand)
Judge: CAROLINA BATIS (Mexico) 129072 - PICKING THE RIGHT NUTRIENT PROFILING MODEL FOR FRONT-OF-PACK NUTRITIONAL LABELING: A RANDOMIZED EXPERIMENT IN AN ONLINE STORE SETTING WITH BRAZILIAN CONSUMERS 128331 - ASSESSING FOOD AVAILABILITY AND HEALTHIER OPTIONS IN AN URBAN CHINESE UNIVERSITY: A CASE STUDY USING THE CHINESE NUTRITION ENVIRONMENT MEASUREMENT SURVEY FOR STORES (C-NEMS-S) 128506 - A TRIAL OF ADULT OBESITY PREVENTION PROCEDURE IN PRIMARY MEDICAL INSTITUTES 128569 - PERCEPTIONS, ATTITUDES, BEHAVIORS, AND BARRIERS TO EFFECTIVE OBESITY CARE: AN EXPLORATORY SURVEY-BASED STUDY AMONG PEOPLE WITH OBESITY AND HEALTHCARE PROFESSIONALS IN INDONESIA 129008 - EMOTIONAL APPEALS IN SODA ADS: IMPACT ON CHILDREN’S CHOICES AND POLICY IMPLICATIONS 129060 - CHILDHOOD OVERWEIGHT AND ITS ASSOCIATION WITH SOCIOECONOMIC AND ENVIRONMENTAL DETERMINANTS IN BRAZILIAN MUNICIPALITIES
Judge: KELLY GARTON (New Zealand)
Judge: CAROLINA BATIS (Mexico) 129072 - PICKING THE RIGHT NUTRIENT PROFILING MODEL FOR FRONT-OF-PACK NUTRITIONAL LABELING: A RANDOMIZED EXPERIMENT IN AN ONLINE STORE SETTING WITH BRAZILIAN CONSUMERS 128331 - ASSESSING FOOD AVAILABILITY AND HEALTHIER OPTIONS IN AN URBAN CHINESE UNIVERSITY: A CASE STUDY USING THE CHINESE NUTRITION ENVIRONMENT MEASUREMENT SURVEY FOR STORES (C-NEMS-S) 128506 - A TRIAL OF ADULT OBESITY PREVENTION PROCEDURE IN PRIMARY MEDICAL INSTITUTES 128569 - PERCEPTIONS, ATTITUDES, BEHAVIORS, AND BARRIERS TO EFFECTIVE OBESITY CARE: AN EXPLORATORY SURVEY-BASED STUDY AMONG PEOPLE WITH OBESITY AND HEALTHCARE PROFESSIONALS IN INDONESIA 129008 - EMOTIONAL APPEALS IN SODA ADS: IMPACT ON CHILDREN’S CHOICES AND POLICY IMPLICATIONS 129060 - CHILDHOOD OVERWEIGHT AND ITS ASSOCIATION WITH SOCIOECONOMIC AND ENVIRONMENTAL DETERMINANTS IN BRAZILIAN MUNICIPALITIES
Judge: KELLY GARTON (New Zealand)
Judge: CAROLINA BATIS (Mexico) 129072 - PICKING THE RIGHT NUTRIENT PROFILING MODEL FOR FRONT-OF-PACK NUTRITIONAL LABELING: A RANDOMIZED EXPERIMENT IN AN ONLINE STORE SETTING WITH BRAZILIAN CONSUMERS 128331 - ASSESSING FOOD AVAILABILITY AND HEALTHIER OPTIONS IN AN URBAN CHINESE UNIVERSITY: A CASE STUDY USING THE CHINESE NUTRITION ENVIRONMENT MEASUREMENT SURVEY FOR STORES (C-NEMS-S) 128506 - A TRIAL OF ADULT OBESITY PREVENTION PROCEDURE IN PRIMARY MEDICAL INSTITUTES 128569 - PERCEPTIONS, ATTITUDES, BEHAVIORS, AND BARRIERS TO EFFECTIVE OBESITY CARE: AN EXPLORATORY SURVEY-BASED STUDY AMONG PEOPLE WITH OBESITY AND HEALTHCARE PROFESSIONALS IN INDONESIA 129008 - EMOTIONAL APPEALS IN SODA ADS: IMPACT ON CHILDREN’S CHOICES AND POLICY IMPLICATIONS 129060 - CHILDHOOD OVERWEIGHT AND ITS ASSOCIATION WITH SOCIOECONOMIC AND ENVIRONMENTAL DETERMINANTS IN BRAZILIAN MUNICIPALITIES
Judge: KELLY GARTON (New Zealand)
Judge: CAROLINA BATIS (Mexico) 129072 - PICKING THE RIGHT NUTRIENT PROFILING MODEL FOR FRONT-OF-PACK NUTRITIONAL LABELING: A RANDOMIZED EXPERIMENT IN AN ONLINE STORE SETTING WITH BRAZILIAN CONSUMERS 128331 - ASSESSING FOOD AVAILABILITY AND HEALTHIER OPTIONS IN AN URBAN CHINESE UNIVERSITY: A CASE STUDY USING THE CHINESE NUTRITION ENVIRONMENT MEASUREMENT SURVEY FOR STORES (C-NEMS-S) 128506 - A TRIAL OF ADULT OBESITY PREVENTION PROCEDURE IN PRIMARY MEDICAL INSTITUTES 128569 - PERCEPTIONS, ATTITUDES, BEHAVIORS, AND BARRIERS TO EFFECTIVE OBESITY CARE: AN EXPLORATORY SURVEY-BASED STUDY AMONG PEOPLE WITH OBESITY AND HEALTHCARE PROFESSIONALS IN INDONESIA 129008 - EMOTIONAL APPEALS IN SODA ADS: IMPACT ON CHILDREN’S CHOICES AND POLICY IMPLICATIONS 129060 - CHILDHOOD OVERWEIGHT AND ITS ASSOCIATION WITH SOCIOECONOMIC AND ENVIRONMENTAL DETERMINANTS IN BRAZILIAN MUNICIPALITIES
Judge: KELLY GARTON (New Zealand)
Judge: CAROLINA BATIS (Mexico) 129072 - PICKING THE RIGHT NUTRIENT PROFILING MODEL FOR FRONT-OF-PACK NUTRITIONAL LABELING: A RANDOMIZED EXPERIMENT IN AN ONLINE STORE SETTING WITH BRAZILIAN CONSUMERS 128331 - ASSESSING FOOD AVAILABILITY AND HEALTHIER OPTIONS IN AN URBAN CHINESE UNIVERSITY: A CASE STUDY USING THE CHINESE NUTRITION ENVIRONMENT MEASUREMENT SURVEY FOR STORES (C-NEMS-S) 128506 - A TRIAL OF ADULT OBESITY PREVENTION PROCEDURE IN PRIMARY MEDICAL INSTITUTES 128569 - PERCEPTIONS, ATTITUDES, BEHAVIORS, AND BARRIERS TO EFFECTIVE OBESITY CARE: AN EXPLORATORY SURVEY-BASED STUDY AMONG PEOPLE WITH OBESITY AND HEALTHCARE PROFESSIONALS IN INDONESIA 129008 - EMOTIONAL APPEALS IN SODA ADS: IMPACT ON CHILDREN’S CHOICES AND POLICY IMPLICATIONS 129060 - CHILDHOOD OVERWEIGHT AND ITS ASSOCIATION WITH SOCIOECONOMIC AND ENVIRONMENTAL DETERMINANTS IN BRAZILIAN MUNICIPALITIES
Judge: KELLY GARTON (New Zealand)
Judge: CAROLINA BATIS (Mexico) 129072 - PICKING THE RIGHT NUTRIENT PROFILING MODEL FOR FRONT-OF-PACK NUTRITIONAL LABELING: A RANDOMIZED EXPERIMENT IN AN ONLINE STORE SETTING WITH BRAZILIAN CONSUMERS 128331 - ASSESSING FOOD AVAILABILITY AND HEALTHIER OPTIONS IN AN URBAN CHINESE UNIVERSITY: A CASE STUDY USING THE CHINESE NUTRITION ENVIRONMENT MEASUREMENT SURVEY FOR STORES (C-NEMS-S) 128506 - A TRIAL OF ADULT OBESITY PREVENTION PROCEDURE IN PRIMARY MEDICAL INSTITUTES 128569 - PERCEPTIONS, ATTITUDES, BEHAVIORS, AND BARRIERS TO EFFECTIVE OBESITY CARE: AN EXPLORATORY SURVEY-BASED STUDY AMONG PEOPLE WITH OBESITY AND HEALTHCARE PROFESSIONALS IN INDONESIA 129008 - EMOTIONAL APPEALS IN SODA ADS: IMPACT ON CHILDREN’S CHOICES AND POLICY IMPLICATIONS 129060 - CHILDHOOD OVERWEIGHT AND ITS ASSOCIATION WITH SOCIOECONOMIC AND ENVIRONMENTAL DETERMINANTS IN BRAZILIAN MUNICIPALITIES
Judge: KELLY GARTON (New Zealand)
Judge: CAROLINA BATIS (Mexico) 129072 - PICKING THE RIGHT NUTRIENT PROFILING MODEL FOR FRONT-OF-PACK NUTRITIONAL LABELING: A RANDOMIZED EXPERIMENT IN AN ONLINE STORE SETTING WITH BRAZILIAN CONSUMERS 128331 - ASSESSING FOOD AVAILABILITY AND HEALTHIER OPTIONS IN AN URBAN CHINESE UNIVERSITY: A CASE STUDY USING THE CHINESE NUTRITION ENVIRONMENT MEASUREMENT SURVEY FOR STORES (C-NEMS-S) 128506 - A TRIAL OF ADULT OBESITY PREVENTION PROCEDURE IN PRIMARY MEDICAL INSTITUTES 128569 - PERCEPTIONS, ATTITUDES, BEHAVIORS, AND BARRIERS TO EFFECTIVE OBESITY CARE: AN EXPLORATORY SURVEY-BASED STUDY AMONG PEOPLE WITH OBESITY AND HEALTHCARE PROFESSIONALS IN INDONESIA 129008 - EMOTIONAL APPEALS IN SODA ADS: IMPACT ON CHILDREN’S CHOICES AND POLICY IMPLICATIONS 129060 - CHILDHOOD OVERWEIGHT AND ITS ASSOCIATION WITH SOCIOECONOMIC AND ENVIRONMENTAL DETERMINANTS IN BRAZILIAN MUNICIPALITIES
Judge: KELLY GARTON (New Zealand)
Judge: CAROLINA BATIS (Mexico) 129072 - PICKING THE RIGHT NUTRIENT PROFILING MODEL FOR FRONT-OF-PACK NUTRITIONAL LABELING: A RANDOMIZED EXPERIMENT IN AN ONLINE STORE SETTING WITH BRAZILIAN CONSUMERS 128331 - ASSESSING FOOD AVAILABILITY AND HEALTHIER OPTIONS IN AN URBAN CHINESE UNIVERSITY: A CASE STUDY USING THE CHINESE NUTRITION ENVIRONMENT MEASUREMENT SURVEY FOR STORES (C-NEMS-S) 128506 - A TRIAL OF ADULT OBESITY PREVENTION PROCEDURE IN PRIMARY MEDICAL INSTITUTES 128569 - PERCEPTIONS, ATTITUDES, BEHAVIORS, AND BARRIERS TO EFFECTIVE OBESITY CARE: AN EXPLORATORY SURVEY-BASED STUDY AMONG PEOPLE WITH OBESITY AND HEALTHCARE PROFESSIONALS IN INDONESIA 129008 - EMOTIONAL APPEALS IN SODA ADS: IMPACT ON CHILDREN’S CHOICES AND POLICY IMPLICATIONS 129060 - CHILDHOOD OVERWEIGHT AND ITS ASSOCIATION WITH SOCIOECONOMIC AND ENVIRONMENTAL DETERMINANTS IN BRAZILIAN MUNICIPALITIES |
||||||||||||||||||||||||||||||||||||||||
Room 6 - Rafael Gomez-Cuevas |
SESSION Main findings on obesity and metabolic diseases in the ELSA Brazil Study 09:30 - 10:30
Coordinator: CRISTIANE BAUERMANN LEITĂO (RS)
Speaker: BRUCE DUNCAN (United States/RS)
Coordinator: CRISTIANE BAUERMANN LEITĂO (RS)
Speaker: BRUCE DUNCAN (United States/RS) |
BREAK 10:30 - 11:00 |
SESSION Abstracts - Clinical 1 11:00 - 12:30
Judge: LUIZ FELLIPE CARVALHO VIOLA (MT)
Judge: CYNTHIA MELISSA VALERIO (RJ) 129700 - ASSESSMENT OF CARDIOMETABOLIC COMORBIDITIES IN ADULTS WITH OSTEOGENESIS IMPERFECTA 128850 - GLP-1 RECEPTOR AGONISTS AND THE RISK OF CHOLANGIOCARCINOMA IN INDIVIDUALS WITH TYPE 2 DIABETES WITH OVERWEIGHT/OBESITY: A LARGE POPULATION-BASED NATIONALWIDE MATCHED COHORT STUDY. 129778 - COMBINATION OF TOPIRAMATE AND SIBUTRAMINE FOR THE TREATMENT OF OBESITY IN REAL-WORLD CLINICAL PRACTICE 129933 - PROBIOTIC SUPPLEMENTATION DID NOT ENHANCE THE EFFECTS OF CONTINUOUS CALORIE RESTRICTION ON BODY ADIPOSITY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL 128926 - RELATIONSHIPS BETWEEN BLOOD DNA METHYLATION, DIET QUALITY AND METABOLIC HEALTH IN A SPANISH POPULATION 129783 - CORRELATION OF THE BUTYRATE-PRODUCING BACTERIUM FECALIBACTERIUM PRAUSNITZII WITH A BETTER METABOLIC PROFILE IN WOMEN Semaglutide 2.4 mg efficacy and safety in people with obesity and knee osteoarthritis: Results from the STEP 9 randomised clinical trial
Judge: LUIZ FELLIPE CARVALHO VIOLA (MT)
Judge: CYNTHIA MELISSA VALERIO (RJ) 129700 - ASSESSMENT OF CARDIOMETABOLIC COMORBIDITIES IN ADULTS WITH OSTEOGENESIS IMPERFECTA 128850 - GLP-1 RECEPTOR AGONISTS AND THE RISK OF CHOLANGIOCARCINOMA IN INDIVIDUALS WITH TYPE 2 DIABETES WITH OVERWEIGHT/OBESITY: A LARGE POPULATION-BASED NATIONALWIDE MATCHED COHORT STUDY. 129778 - COMBINATION OF TOPIRAMATE AND SIBUTRAMINE FOR THE TREATMENT OF OBESITY IN REAL-WORLD CLINICAL PRACTICE 129933 - PROBIOTIC SUPPLEMENTATION DID NOT ENHANCE THE EFFECTS OF CONTINUOUS CALORIE RESTRICTION ON BODY ADIPOSITY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL 128926 - RELATIONSHIPS BETWEEN BLOOD DNA METHYLATION, DIET QUALITY AND METABOLIC HEALTH IN A SPANISH POPULATION 129783 - CORRELATION OF THE BUTYRATE-PRODUCING BACTERIUM FECALIBACTERIUM PRAUSNITZII WITH A BETTER METABOLIC PROFILE IN WOMEN Semaglutide 2.4 mg efficacy and safety in people with obesity and knee osteoarthritis: Results from the STEP 9 randomised clinical trial
Judge: LUIZ FELLIPE CARVALHO VIOLA (MT)
Judge: CYNTHIA MELISSA VALERIO (RJ) 129700 - ASSESSMENT OF CARDIOMETABOLIC COMORBIDITIES IN ADULTS WITH OSTEOGENESIS IMPERFECTA 128850 - GLP-1 RECEPTOR AGONISTS AND THE RISK OF CHOLANGIOCARCINOMA IN INDIVIDUALS WITH TYPE 2 DIABETES WITH OVERWEIGHT/OBESITY: A LARGE POPULATION-BASED NATIONALWIDE MATCHED COHORT STUDY. 129778 - COMBINATION OF TOPIRAMATE AND SIBUTRAMINE FOR THE TREATMENT OF OBESITY IN REAL-WORLD CLINICAL PRACTICE 129933 - PROBIOTIC SUPPLEMENTATION DID NOT ENHANCE THE EFFECTS OF CONTINUOUS CALORIE RESTRICTION ON BODY ADIPOSITY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL 128926 - RELATIONSHIPS BETWEEN BLOOD DNA METHYLATION, DIET QUALITY AND METABOLIC HEALTH IN A SPANISH POPULATION 129783 - CORRELATION OF THE BUTYRATE-PRODUCING BACTERIUM FECALIBACTERIUM PRAUSNITZII WITH A BETTER METABOLIC PROFILE IN WOMEN Semaglutide 2.4 mg efficacy and safety in people with obesity and knee osteoarthritis: Results from the STEP 9 randomised clinical trial
Judge: LUIZ FELLIPE CARVALHO VIOLA (MT)
Judge: CYNTHIA MELISSA VALERIO (RJ) 129700 - ASSESSMENT OF CARDIOMETABOLIC COMORBIDITIES IN ADULTS WITH OSTEOGENESIS IMPERFECTA 128850 - GLP-1 RECEPTOR AGONISTS AND THE RISK OF CHOLANGIOCARCINOMA IN INDIVIDUALS WITH TYPE 2 DIABETES WITH OVERWEIGHT/OBESITY: A LARGE POPULATION-BASED NATIONALWIDE MATCHED COHORT STUDY. 129778 - COMBINATION OF TOPIRAMATE AND SIBUTRAMINE FOR THE TREATMENT OF OBESITY IN REAL-WORLD CLINICAL PRACTICE 129933 - PROBIOTIC SUPPLEMENTATION DID NOT ENHANCE THE EFFECTS OF CONTINUOUS CALORIE RESTRICTION ON BODY ADIPOSITY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL 128926 - RELATIONSHIPS BETWEEN BLOOD DNA METHYLATION, DIET QUALITY AND METABOLIC HEALTH IN A SPANISH POPULATION 129783 - CORRELATION OF THE BUTYRATE-PRODUCING BACTERIUM FECALIBACTERIUM PRAUSNITZII WITH A BETTER METABOLIC PROFILE IN WOMEN Semaglutide 2.4 mg efficacy and safety in people with obesity and knee osteoarthritis: Results from the STEP 9 randomised clinical trial
Judge: LUIZ FELLIPE CARVALHO VIOLA (MT)
Judge: CYNTHIA MELISSA VALERIO (RJ) 129700 - ASSESSMENT OF CARDIOMETABOLIC COMORBIDITIES IN ADULTS WITH OSTEOGENESIS IMPERFECTA 128850 - GLP-1 RECEPTOR AGONISTS AND THE RISK OF CHOLANGIOCARCINOMA IN INDIVIDUALS WITH TYPE 2 DIABETES WITH OVERWEIGHT/OBESITY: A LARGE POPULATION-BASED NATIONALWIDE MATCHED COHORT STUDY. 129778 - COMBINATION OF TOPIRAMATE AND SIBUTRAMINE FOR THE TREATMENT OF OBESITY IN REAL-WORLD CLINICAL PRACTICE 129933 - PROBIOTIC SUPPLEMENTATION DID NOT ENHANCE THE EFFECTS OF CONTINUOUS CALORIE RESTRICTION ON BODY ADIPOSITY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL 128926 - RELATIONSHIPS BETWEEN BLOOD DNA METHYLATION, DIET QUALITY AND METABOLIC HEALTH IN A SPANISH POPULATION 129783 - CORRELATION OF THE BUTYRATE-PRODUCING BACTERIUM FECALIBACTERIUM PRAUSNITZII WITH A BETTER METABOLIC PROFILE IN WOMEN Semaglutide 2.4 mg efficacy and safety in people with obesity and knee osteoarthritis: Results from the STEP 9 randomised clinical trial
Judge: LUIZ FELLIPE CARVALHO VIOLA (MT)
Judge: CYNTHIA MELISSA VALERIO (RJ) 129700 - ASSESSMENT OF CARDIOMETABOLIC COMORBIDITIES IN ADULTS WITH OSTEOGENESIS IMPERFECTA 128850 - GLP-1 RECEPTOR AGONISTS AND THE RISK OF CHOLANGIOCARCINOMA IN INDIVIDUALS WITH TYPE 2 DIABETES WITH OVERWEIGHT/OBESITY: A LARGE POPULATION-BASED NATIONALWIDE MATCHED COHORT STUDY. 129778 - COMBINATION OF TOPIRAMATE AND SIBUTRAMINE FOR THE TREATMENT OF OBESITY IN REAL-WORLD CLINICAL PRACTICE 129933 - PROBIOTIC SUPPLEMENTATION DID NOT ENHANCE THE EFFECTS OF CONTINUOUS CALORIE RESTRICTION ON BODY ADIPOSITY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL 128926 - RELATIONSHIPS BETWEEN BLOOD DNA METHYLATION, DIET QUALITY AND METABOLIC HEALTH IN A SPANISH POPULATION 129783 - CORRELATION OF THE BUTYRATE-PRODUCING BACTERIUM FECALIBACTERIUM PRAUSNITZII WITH A BETTER METABOLIC PROFILE IN WOMEN Semaglutide 2.4 mg efficacy and safety in people with obesity and knee osteoarthritis: Results from the STEP 9 randomised clinical trial
Judge: LUIZ FELLIPE CARVALHO VIOLA (MT)
Judge: CYNTHIA MELISSA VALERIO (RJ) 129700 - ASSESSMENT OF CARDIOMETABOLIC COMORBIDITIES IN ADULTS WITH OSTEOGENESIS IMPERFECTA 128850 - GLP-1 RECEPTOR AGONISTS AND THE RISK OF CHOLANGIOCARCINOMA IN INDIVIDUALS WITH TYPE 2 DIABETES WITH OVERWEIGHT/OBESITY: A LARGE POPULATION-BASED NATIONALWIDE MATCHED COHORT STUDY. 129778 - COMBINATION OF TOPIRAMATE AND SIBUTRAMINE FOR THE TREATMENT OF OBESITY IN REAL-WORLD CLINICAL PRACTICE 129933 - PROBIOTIC SUPPLEMENTATION DID NOT ENHANCE THE EFFECTS OF CONTINUOUS CALORIE RESTRICTION ON BODY ADIPOSITY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL 128926 - RELATIONSHIPS BETWEEN BLOOD DNA METHYLATION, DIET QUALITY AND METABOLIC HEALTH IN A SPANISH POPULATION 129783 - CORRELATION OF THE BUTYRATE-PRODUCING BACTERIUM FECALIBACTERIUM PRAUSNITZII WITH A BETTER METABOLIC PROFILE IN WOMEN Semaglutide 2.4 mg efficacy and safety in people with obesity and knee osteoarthritis: Results from the STEP 9 randomised clinical trial
Judge: LUIZ FELLIPE CARVALHO VIOLA (MT)
Judge: CYNTHIA MELISSA VALERIO (RJ) 129700 - ASSESSMENT OF CARDIOMETABOLIC COMORBIDITIES IN ADULTS WITH OSTEOGENESIS IMPERFECTA 128850 - GLP-1 RECEPTOR AGONISTS AND THE RISK OF CHOLANGIOCARCINOMA IN INDIVIDUALS WITH TYPE 2 DIABETES WITH OVERWEIGHT/OBESITY: A LARGE POPULATION-BASED NATIONALWIDE MATCHED COHORT STUDY. 129778 - COMBINATION OF TOPIRAMATE AND SIBUTRAMINE FOR THE TREATMENT OF OBESITY IN REAL-WORLD CLINICAL PRACTICE 129933 - PROBIOTIC SUPPLEMENTATION DID NOT ENHANCE THE EFFECTS OF CONTINUOUS CALORIE RESTRICTION ON BODY ADIPOSITY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL 128926 - RELATIONSHIPS BETWEEN BLOOD DNA METHYLATION, DIET QUALITY AND METABOLIC HEALTH IN A SPANISH POPULATION 129783 - CORRELATION OF THE BUTYRATE-PRODUCING BACTERIUM FECALIBACTERIUM PRAUSNITZII WITH A BETTER METABOLIC PROFILE IN WOMEN Semaglutide 2.4 mg efficacy and safety in people with obesity and knee osteoarthritis: Results from the STEP 9 randomised clinical trial
Judge: LUIZ FELLIPE CARVALHO VIOLA (MT)
Judge: CYNTHIA MELISSA VALERIO (RJ) 129700 - ASSESSMENT OF CARDIOMETABOLIC COMORBIDITIES IN ADULTS WITH OSTEOGENESIS IMPERFECTA 128850 - GLP-1 RECEPTOR AGONISTS AND THE RISK OF CHOLANGIOCARCINOMA IN INDIVIDUALS WITH TYPE 2 DIABETES WITH OVERWEIGHT/OBESITY: A LARGE POPULATION-BASED NATIONALWIDE MATCHED COHORT STUDY. 129778 - COMBINATION OF TOPIRAMATE AND SIBUTRAMINE FOR THE TREATMENT OF OBESITY IN REAL-WORLD CLINICAL PRACTICE 129933 - PROBIOTIC SUPPLEMENTATION DID NOT ENHANCE THE EFFECTS OF CONTINUOUS CALORIE RESTRICTION ON BODY ADIPOSITY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL 128926 - RELATIONSHIPS BETWEEN BLOOD DNA METHYLATION, DIET QUALITY AND METABOLIC HEALTH IN A SPANISH POPULATION 129783 - CORRELATION OF THE BUTYRATE-PRODUCING BACTERIUM FECALIBACTERIUM PRAUSNITZII WITH A BETTER METABOLIC PROFILE IN WOMEN Semaglutide 2.4 mg efficacy and safety in people with obesity and knee osteoarthritis: Results from the STEP 9 randomised clinical trial |
BREAK 12:30 - 14:00 |
SESSION Abstracts - Clinical 2 14:00 - 15:30
Judge: CINTIA CERCATO (SP)
Judge: JOĂO EDUARDO NUNES SALLES (SP) Survodutide, a glucagon receptor/glucagon-like peptide-1 receptor dual agonist, improves metabolic risk factors in adults living with obesity: analysis of a placebo-controlled, randomised phase 2 trial 129848 - ASSESSMENT OF THE PERFORMANCE OF BODY ADIPOSITY INDEXES, RELATIVE FAT MASS AND BODY ROUNDNESS IN THE ASSESSMENT OF BODY ADIPOSITY AND INSULIN RESISTANCE IN ADULTS 128863 - ADOLESCENTS WITH HIGHER CALORIC INTAKE AT LATER HOURS ARE MORE LIKELY TO HAVE AN INCREASED RISK OF EXCESS WEIGHT: RESULTS FROM A POPULATION-BASED STUDY 129851 - GRAZING AFTER BARIATRIC SURGERY: PSYCHIATRIC COMORBIDITY AND WEIGHT OUTCOMES 128961 - OPTIMIZATION OF PATIENT ENGAGEMENT IN THE PHASE 3 CLINICAL TRIAL PROGRAM FOR SURVODUTIDE IN OBESITY THROUGH SIMULATION 128571 - METABOLIC PROFILE AND ITS RISKS IN A NON-DIABETIC POPULATION UNDERGOING KIDNEY TRANSPLANT 128581 - THE ANTIVIRAL IMMUNE DEFENSE MAY BE ADVERSELY INFLUENCED BY WEIGHT LOSS THROUGH A CALORIE RESTRICTION PROGRAM IN OBESE WOMEN
Judge: CINTIA CERCATO (SP)
Judge: JOĂO EDUARDO NUNES SALLES (SP) Survodutide, a glucagon receptor/glucagon-like peptide-1 receptor dual agonist, improves metabolic risk factors in adults living with obesity: analysis of a placebo-controlled, randomised phase 2 trial 129848 - ASSESSMENT OF THE PERFORMANCE OF BODY ADIPOSITY INDEXES, RELATIVE FAT MASS AND BODY ROUNDNESS IN THE ASSESSMENT OF BODY ADIPOSITY AND INSULIN RESISTANCE IN ADULTS 128863 - ADOLESCENTS WITH HIGHER CALORIC INTAKE AT LATER HOURS ARE MORE LIKELY TO HAVE AN INCREASED RISK OF EXCESS WEIGHT: RESULTS FROM A POPULATION-BASED STUDY 129851 - GRAZING AFTER BARIATRIC SURGERY: PSYCHIATRIC COMORBIDITY AND WEIGHT OUTCOMES 128961 - OPTIMIZATION OF PATIENT ENGAGEMENT IN THE PHASE 3 CLINICAL TRIAL PROGRAM FOR SURVODUTIDE IN OBESITY THROUGH SIMULATION 128571 - METABOLIC PROFILE AND ITS RISKS IN A NON-DIABETIC POPULATION UNDERGOING KIDNEY TRANSPLANT 128581 - THE ANTIVIRAL IMMUNE DEFENSE MAY BE ADVERSELY INFLUENCED BY WEIGHT LOSS THROUGH A CALORIE RESTRICTION PROGRAM IN OBESE WOMEN
Judge: CINTIA CERCATO (SP)
Judge: JOĂO EDUARDO NUNES SALLES (SP) Survodutide, a glucagon receptor/glucagon-like peptide-1 receptor dual agonist, improves metabolic risk factors in adults living with obesity: analysis of a placebo-controlled, randomised phase 2 trial 129848 - ASSESSMENT OF THE PERFORMANCE OF BODY ADIPOSITY INDEXES, RELATIVE FAT MASS AND BODY ROUNDNESS IN THE ASSESSMENT OF BODY ADIPOSITY AND INSULIN RESISTANCE IN ADULTS 128863 - ADOLESCENTS WITH HIGHER CALORIC INTAKE AT LATER HOURS ARE MORE LIKELY TO HAVE AN INCREASED RISK OF EXCESS WEIGHT: RESULTS FROM A POPULATION-BASED STUDY 129851 - GRAZING AFTER BARIATRIC SURGERY: PSYCHIATRIC COMORBIDITY AND WEIGHT OUTCOMES 128961 - OPTIMIZATION OF PATIENT ENGAGEMENT IN THE PHASE 3 CLINICAL TRIAL PROGRAM FOR SURVODUTIDE IN OBESITY THROUGH SIMULATION 128571 - METABOLIC PROFILE AND ITS RISKS IN A NON-DIABETIC POPULATION UNDERGOING KIDNEY TRANSPLANT 128581 - THE ANTIVIRAL IMMUNE DEFENSE MAY BE ADVERSELY INFLUENCED BY WEIGHT LOSS THROUGH A CALORIE RESTRICTION PROGRAM IN OBESE WOMEN
Judge: CINTIA CERCATO (SP)
Judge: JOĂO EDUARDO NUNES SALLES (SP) Survodutide, a glucagon receptor/glucagon-like peptide-1 receptor dual agonist, improves metabolic risk factors in adults living with obesity: analysis of a placebo-controlled, randomised phase 2 trial 129848 - ASSESSMENT OF THE PERFORMANCE OF BODY ADIPOSITY INDEXES, RELATIVE FAT MASS AND BODY ROUNDNESS IN THE ASSESSMENT OF BODY ADIPOSITY AND INSULIN RESISTANCE IN ADULTS 128863 - ADOLESCENTS WITH HIGHER CALORIC INTAKE AT LATER HOURS ARE MORE LIKELY TO HAVE AN INCREASED RISK OF EXCESS WEIGHT: RESULTS FROM A POPULATION-BASED STUDY 129851 - GRAZING AFTER BARIATRIC SURGERY: PSYCHIATRIC COMORBIDITY AND WEIGHT OUTCOMES 128961 - OPTIMIZATION OF PATIENT ENGAGEMENT IN THE PHASE 3 CLINICAL TRIAL PROGRAM FOR SURVODUTIDE IN OBESITY THROUGH SIMULATION 128571 - METABOLIC PROFILE AND ITS RISKS IN A NON-DIABETIC POPULATION UNDERGOING KIDNEY TRANSPLANT 128581 - THE ANTIVIRAL IMMUNE DEFENSE MAY BE ADVERSELY INFLUENCED BY WEIGHT LOSS THROUGH A CALORIE RESTRICTION PROGRAM IN OBESE WOMEN
Judge: CINTIA CERCATO (SP)
Judge: JOĂO EDUARDO NUNES SALLES (SP) Survodutide, a glucagon receptor/glucagon-like peptide-1 receptor dual agonist, improves metabolic risk factors in adults living with obesity: analysis of a placebo-controlled, randomised phase 2 trial 129848 - ASSESSMENT OF THE PERFORMANCE OF BODY ADIPOSITY INDEXES, RELATIVE FAT MASS AND BODY ROUNDNESS IN THE ASSESSMENT OF BODY ADIPOSITY AND INSULIN RESISTANCE IN ADULTS 128863 - ADOLESCENTS WITH HIGHER CALORIC INTAKE AT LATER HOURS ARE MORE LIKELY TO HAVE AN INCREASED RISK OF EXCESS WEIGHT: RESULTS FROM A POPULATION-BASED STUDY 129851 - GRAZING AFTER BARIATRIC SURGERY: PSYCHIATRIC COMORBIDITY AND WEIGHT OUTCOMES 128961 - OPTIMIZATION OF PATIENT ENGAGEMENT IN THE PHASE 3 CLINICAL TRIAL PROGRAM FOR SURVODUTIDE IN OBESITY THROUGH SIMULATION 128571 - METABOLIC PROFILE AND ITS RISKS IN A NON-DIABETIC POPULATION UNDERGOING KIDNEY TRANSPLANT 128581 - THE ANTIVIRAL IMMUNE DEFENSE MAY BE ADVERSELY INFLUENCED BY WEIGHT LOSS THROUGH A CALORIE RESTRICTION PROGRAM IN OBESE WOMEN
Judge: CINTIA CERCATO (SP)
Judge: JOĂO EDUARDO NUNES SALLES (SP) Survodutide, a glucagon receptor/glucagon-like peptide-1 receptor dual agonist, improves metabolic risk factors in adults living with obesity: analysis of a placebo-controlled, randomised phase 2 trial 129848 - ASSESSMENT OF THE PERFORMANCE OF BODY ADIPOSITY INDEXES, RELATIVE FAT MASS AND BODY ROUNDNESS IN THE ASSESSMENT OF BODY ADIPOSITY AND INSULIN RESISTANCE IN ADULTS 128863 - ADOLESCENTS WITH HIGHER CALORIC INTAKE AT LATER HOURS ARE MORE LIKELY TO HAVE AN INCREASED RISK OF EXCESS WEIGHT: RESULTS FROM A POPULATION-BASED STUDY 129851 - GRAZING AFTER BARIATRIC SURGERY: PSYCHIATRIC COMORBIDITY AND WEIGHT OUTCOMES 128961 - OPTIMIZATION OF PATIENT ENGAGEMENT IN THE PHASE 3 CLINICAL TRIAL PROGRAM FOR SURVODUTIDE IN OBESITY THROUGH SIMULATION 128571 - METABOLIC PROFILE AND ITS RISKS IN A NON-DIABETIC POPULATION UNDERGOING KIDNEY TRANSPLANT 128581 - THE ANTIVIRAL IMMUNE DEFENSE MAY BE ADVERSELY INFLUENCED BY WEIGHT LOSS THROUGH A CALORIE RESTRICTION PROGRAM IN OBESE WOMEN
Judge: CINTIA CERCATO (SP)
Judge: JOĂO EDUARDO NUNES SALLES (SP) Survodutide, a glucagon receptor/glucagon-like peptide-1 receptor dual agonist, improves metabolic risk factors in adults living with obesity: analysis of a placebo-controlled, randomised phase 2 trial 129848 - ASSESSMENT OF THE PERFORMANCE OF BODY ADIPOSITY INDEXES, RELATIVE FAT MASS AND BODY ROUNDNESS IN THE ASSESSMENT OF BODY ADIPOSITY AND INSULIN RESISTANCE IN ADULTS 128863 - ADOLESCENTS WITH HIGHER CALORIC INTAKE AT LATER HOURS ARE MORE LIKELY TO HAVE AN INCREASED RISK OF EXCESS WEIGHT: RESULTS FROM A POPULATION-BASED STUDY 129851 - GRAZING AFTER BARIATRIC SURGERY: PSYCHIATRIC COMORBIDITY AND WEIGHT OUTCOMES 128961 - OPTIMIZATION OF PATIENT ENGAGEMENT IN THE PHASE 3 CLINICAL TRIAL PROGRAM FOR SURVODUTIDE IN OBESITY THROUGH SIMULATION 128571 - METABOLIC PROFILE AND ITS RISKS IN A NON-DIABETIC POPULATION UNDERGOING KIDNEY TRANSPLANT 128581 - THE ANTIVIRAL IMMUNE DEFENSE MAY BE ADVERSELY INFLUENCED BY WEIGHT LOSS THROUGH A CALORIE RESTRICTION PROGRAM IN OBESE WOMEN
Judge: CINTIA CERCATO (SP)
Judge: JOĂO EDUARDO NUNES SALLES (SP) Survodutide, a glucagon receptor/glucagon-like peptide-1 receptor dual agonist, improves metabolic risk factors in adults living with obesity: analysis of a placebo-controlled, randomised phase 2 trial 129848 - ASSESSMENT OF THE PERFORMANCE OF BODY ADIPOSITY INDEXES, RELATIVE FAT MASS AND BODY ROUNDNESS IN THE ASSESSMENT OF BODY ADIPOSITY AND INSULIN RESISTANCE IN ADULTS 128863 - ADOLESCENTS WITH HIGHER CALORIC INTAKE AT LATER HOURS ARE MORE LIKELY TO HAVE AN INCREASED RISK OF EXCESS WEIGHT: RESULTS FROM A POPULATION-BASED STUDY 129851 - GRAZING AFTER BARIATRIC SURGERY: PSYCHIATRIC COMORBIDITY AND WEIGHT OUTCOMES 128961 - OPTIMIZATION OF PATIENT ENGAGEMENT IN THE PHASE 3 CLINICAL TRIAL PROGRAM FOR SURVODUTIDE IN OBESITY THROUGH SIMULATION 128571 - METABOLIC PROFILE AND ITS RISKS IN A NON-DIABETIC POPULATION UNDERGOING KIDNEY TRANSPLANT 128581 - THE ANTIVIRAL IMMUNE DEFENSE MAY BE ADVERSELY INFLUENCED BY WEIGHT LOSS THROUGH A CALORIE RESTRICTION PROGRAM IN OBESE WOMEN
Judge: CINTIA CERCATO (SP)
Judge: JOĂO EDUARDO NUNES SALLES (SP) Survodutide, a glucagon receptor/glucagon-like peptide-1 receptor dual agonist, improves metabolic risk factors in adults living with obesity: analysis of a placebo-controlled, randomised phase 2 trial 129848 - ASSESSMENT OF THE PERFORMANCE OF BODY ADIPOSITY INDEXES, RELATIVE FAT MASS AND BODY ROUNDNESS IN THE ASSESSMENT OF BODY ADIPOSITY AND INSULIN RESISTANCE IN ADULTS 128863 - ADOLESCENTS WITH HIGHER CALORIC INTAKE AT LATER HOURS ARE MORE LIKELY TO HAVE AN INCREASED RISK OF EXCESS WEIGHT: RESULTS FROM A POPULATION-BASED STUDY 129851 - GRAZING AFTER BARIATRIC SURGERY: PSYCHIATRIC COMORBIDITY AND WEIGHT OUTCOMES 128961 - OPTIMIZATION OF PATIENT ENGAGEMENT IN THE PHASE 3 CLINICAL TRIAL PROGRAM FOR SURVODUTIDE IN OBESITY THROUGH SIMULATION 128571 - METABOLIC PROFILE AND ITS RISKS IN A NON-DIABETIC POPULATION UNDERGOING KIDNEY TRANSPLANT 128581 - THE ANTIVIRAL IMMUNE DEFENSE MAY BE ADVERSELY INFLUENCED BY WEIGHT LOSS THROUGH A CALORIE RESTRICTION PROGRAM IN OBESE WOMEN |
REFRESHMENT BREAK AND POSTER SESSION 15:30 - 16:30 |
MEET THE EXPERT Screening, diagnosis, treatment and follow up of patients with MASLD/MASH 16:30 - 17:30
Speaker: CLAUDIA PINTO MARQUES SOUZA DE OLIVEIRA (SP)
Speaker: RODRIGO DE OLIVEIRA MOREIRA (RJ)
Speaker: CLAUDIA PINTO MARQUES SOUZA DE OLIVEIRA (SP)
Speaker: RODRIGO DE OLIVEIRA MOREIRA (RJ) |
MEET THE EXPERT Sleep apnea – from diagnosis, to the clinical impact of CPAP and weight loss 17:30 - 18:30
Speaker: LUCIANO FERREIRA DRAGER (SP)
Speaker: GERALDO LORENZI FILHO (SP)
Speaker: LUCIANO FERREIRA DRAGER (SP)
Speaker: GERALDO LORENZI FILHO (SP) |
|||||||||||||||||||||||||||||||||||||||||
Poster Area - Per Bjorntorp |
REFRESHMENT BREAK AND POSTER SESSION 15:30 - 16:30
E-poster 1
Judge: MARIA EDNA DE MELO (SP) E-poster 2 Judge: KELLY GARTON (New Zealand) E-poster 3 Judge: CAROLINA BATIS (Mexico) E-poster 4 Judge: RAFAEL CLARO (MG)
E-poster 1
Judge: MARIA EDNA DE MELO (SP) E-poster 2 Judge: KELLY GARTON (New Zealand) E-poster 3 Judge: CAROLINA BATIS (Mexico) E-poster 4 Judge: RAFAEL CLARO (MG)
E-poster 1
Judge: MARIA EDNA DE MELO (SP) E-poster 2 Judge: KELLY GARTON (New Zealand) E-poster 3 Judge: CAROLINA BATIS (Mexico) E-poster 4 Judge: RAFAEL CLARO (MG)
E-poster 1
Judge: MARIA EDNA DE MELO (SP) E-poster 2 Judge: KELLY GARTON (New Zealand) E-poster 3 Judge: CAROLINA BATIS (Mexico) E-poster 4 Judge: RAFAEL CLARO (MG) |
||||||||||||||||||||||||||||||||||||||||||||||||